(4S,4aS,6S,12aS)-4-Dimethylamino-3,6,10,12,12a-pentahydroxy-4a,6-dimethyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide

ID: ALA1440

Chembl Id: CHEMBL1440

Max Phase: Approved

First Approval: 2006

Molecular Formula: C22H24N2O8

Molecular Weight: 444.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Tetracycline | NSC-108579

Synonyms from Alternative Forms(24): Tetracycline hydrochloride | Neocycline b | Tetracycline hcl | Tetracyclini hydrochloridum | Vetquamycin 324 | NSC-757338 | Achromycin | Achromycin v | Actisite | Bristacycline | Cyclopar | Latycin | Panmycin | Retet | Robitet | Sumycin | Tetrachel | Tetracyn | Tetramed | Topicycline | Tetracycline phosphate complex | Tetracycline metaphosphate | Tetracycline hexametaphosphate | Tetrex

Trade Names(11): Achromycin | Achromycin v | Cyclopar | Economycin | Liquamycin | Panmycin | Supramycin | Sustamycin | Tetrabid organon | Tetracyn | Vetquamycin

Canonical SMILES:  CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12

Standard InChI:  InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1

Standard InChI Key:  OFVLGDICTFRJMM-WESIUVDSSA-N

Alternative Forms

  1. Parent:

  2. Alternative Forms:

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RY12 Tclin Purinergic receptor P2Y12 (2369 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYSLTR1 Tclin Cysteinyl leukotriene receptor 1 (2118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM5 Tclin Muscarinic acetylcholine receptor M5 (4677 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ELANE Tclin Leukocyte elastase (8173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXAS1 Tchem Thromboxane-A synthase (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR1 Tclin Neurokinin 1 receptor (6273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTAFR Tchem Platelet activating factor receptor (2575 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BDKRB2 Tclin Bradykinin B2 receptor (3970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC4R Tclin Melanocortin receptor 4 (10016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR2 Tchem Neurokinin 2 receptor (3341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCKAR Tclin Cholecystokinin A receptor (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPY1R Tchem Neuropeptide Y receptor type 1 (5019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPY2R Tchem Neuropeptide Y receptor type 2 (3731 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSG Tchem Cathepsin G (2304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR4 Tclin C-C chemokine receptor type 4 (2819 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR6 Tchem Serotonin 6 (5-HT6) receptor (9749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA4 Tclin Neuronal acetylcholine receptor protein alpha-4 subunit (1265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR2 Tchem Angiotensin II type 2 (AT-2) receptor (2549 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALB Tchem Serum albumin (2651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR2 Tchem Interleukin-8 receptor B (3491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC3R Tchem Melanocortin receptor 3 (5659 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC5R Tchem Melanocortin receptor 5 (4283 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP13 Tchem Matrix metalloproteinase 13 (4133 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP8 Tchem Matrix metalloproteinase 8 (1942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4D Tclin Phosphodiesterase 4D (3546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPN7 Tchem Protein-tyrosine phosphatase LC-PTP (886 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR1 Tchem Interleukin-8 receptor A (2256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR2 Tchem C-C chemokine receptor type 2 (5628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CASP1 Tchem Caspase-1 (6235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCA Tchem Protein kinase C alpha (5923 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FYN Tclin Tyrosine-protein kinase FYN (5308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPRC Tchem Leukocyte common antigen (2317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPP3CA Tchem Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform (1831 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TERT Tchem Telomerase reverse transcriptase (2428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SOD1 Tchem Superoxide dismutase (173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GNPAT Tchem Acyl-CoA:dihydroxyacetonephosphateacyltransferase (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2E1 Tchem Cytochrome P450 2E1 (2174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2A6 Tchem Cytochrome P450 2A6 (2861 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
5637 (630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MG-63 (795 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW1353 (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HaCaT (4069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VIPR1 Tchem Vasoactive intestinal polypeptide receptor 1 (1904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A1 Tchem Solute carrier family 22 member 1 (646 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC2 Tchem Canalicular multispecific organic anion transporter 1 (1191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2RL1 Tchem Proteinase-activated receptor 2 (703 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC3 Tbio Canalicular multispecific organic anion transporter 2 (718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PADI4 Tchem Protein-arginine deiminase type-4 (309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNCA Tchem Alpha-synuclein (10960 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UGT1A1 Tchem UDP-glucuronosyltransferase 1-1 (448 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
microRNA 21 (64692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A6 Tclin Solute carrier family 22 member 6 (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A8 Tclin Solute carrier family 22 member 8 (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B1 Tchem Solute carrier organic anion transporter family member 1B1 (2672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (2517 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO2B1 Tchem Solute carrier organic anion transporter family member 2B1 (580 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC4 Tchem Multidrug resistance-associated protein 4 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UGT1A6 Tbio UDP-glucuronosyltransferase 1-6 (221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UGT1A9 Tbio UDP-glucuronosyltransferase 1-9 (343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IAPP Tchem Islet amyloid polypeptide (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A7 Tbio Solute carrier family 22 member 7 (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A11 Tclin Solute carrier family 22 member 11 (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Adrenergic receptor beta (1214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSP90AA1 Tchem Heat shock protein HSP90 (3606 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hydroxyapatite (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

mdfA Multidrug translocase mdfA (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecalis (29875 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Actinomyces viscosus (309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Porphyromonas gingivalis (651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aggregatibacter actinomycetemcomitans (150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bos taurus (956 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus (1748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Helicobacter pylori (3113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Xanthomonas campestris (200 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Xanthomonas oryzae (286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecium (13803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus lugdunensis (349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pneumoniae (31063 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus influenzae (8812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pyogenes (16140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Neisseria gonorrhoeae (1461 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus cereus (7522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus luteus (7463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus vulgaris (5823 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium smegmatis (8003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Listeria monocytogenes (2626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus mirabilis (3894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Colletotrichum (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Botrytis (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beauveria bassiana (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhi (4293 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus (3973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus sp. (212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cutibacterium acnes (887 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium jeikeium (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium diphtheriae (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium amycolatum (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium minutissimum (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus equi subsp. zooepidemicus (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus pumilus (984 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus mutans (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus agalactiae (1777 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Stenotrophomonas maltophilia (1743 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae subsp. pneumoniae (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter freundii (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pasteurianus (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus equinus (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus sp. (496 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Priestia megaterium (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Microbotryum violaceum (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
[Chlorella] fusca (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Benjaminiella poitrasii (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Yarrowia lipolytica (267 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fusarium oxysporum (3998 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Campylobacter jejuni (634 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus sp. 'group A' (3417 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus sp. 'group B' (533 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus viridans (303 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella enterica subsp. enterica serovar Typhi str. CT18 (145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
tetA Tetracycline resistance protein, class B (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Monoamine oxidase A (484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOB Monoamine oxidase B (894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella enterica subsp. enterica (623 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.A1 (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bifidobacterium thermophilum (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lactobacillus johnsonii (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella sp. (156 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter sp. (336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacteriaceae (669 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Metamycoplasma hominis (88 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ureaplasma (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clostridioides difficile (2968 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus flavus (8875 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichoderma viride (1263 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus niger (16508 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Penicillium chrysogenum (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella enterica (1497 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serratia marcescens (3237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brevibacterium epidermidis (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dermabacter hominis (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trueperella pyogenes (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus fumigatus (16427 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella enteritidis (727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium pseudodiphtheriticum (105 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium striatum (66 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium urealyticum (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prescottella equi (132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus anthracis (2936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Campylobacter coli (196 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium xerosis (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycoplasmoides pneumoniae (351 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium ulcerans (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Burkholderia pseudomallei (576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella aerogenes (4963 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis variant bovis BCG (1626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus constellatus (189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus oralis (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus intermedius (230 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus mitis (390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella sp. (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptomyces coelicolor (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Edwardsiella ictaluri (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas fluorescens (1630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella flexneri (1836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus hirae (484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia stuartii (425 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter lwoffii (550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas putida (467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter calcoaceticus (618 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vibrio cholerae (1211 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aeromonas hydrophila (292 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aeromonas caviae (83 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aeromonas sobria (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella (646 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aeromonas sp. (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vibrio (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter radioresistens (97 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus (1598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella sonnei (625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella sp. (105 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Neisseria meningitidis (411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
murI Glutamate racemase (48 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus hominis (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus haemolyticus (1695 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus simulans (400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mammaliicoccus sciuri (248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chlamydia trachomatis (699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pasteurella multocida (1166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Morganella morganii (1291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacteroides chelonae (540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
agrA Accessory gene regulator protein A (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus suis (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Legionella pneumophila (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nakaseomyces glabratus (9108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brevibacillus brevis (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akr1b1 Aldose reductase (4007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Glra2 Glycine receptor (1745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Insr Insulin receptor (1750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LTC4S Leukotriene C4 synthase (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX15 Arachidonate 15-lipoxygenase (2064 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos1 Nitric-oxide synthase, brain (2987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Progesterone receptor (1742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Angiotensin-converting enzyme (2863 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1a Serotonin 1a (5-HT1a) receptor (8655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1b Serotonin 1b (5-HT1b) receptor (2343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR4 Serotonin 4 (5-HT4) receptor (2870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus thuringiensis (718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Photobacterium leiognathi (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rpsB Bacterial 70S ribosome (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium vivax (152 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pectobacterium carotovorum (295 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus saprophyticus (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nocardia canis (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyberlindnera jadinii (900 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Xanthomonas euvesicatoria pv. sesami (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Superoxide dismutase [Cu-Zn] (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oryctolagus cuniculus (11301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus flavus (568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus spizizenii (1898 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bordetella bronchiseptica (483 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Agrobacterium tumefaciens (620 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Burkholderia cenocepacia (164 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida tropicalis (8381 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida parapsilosis (8521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella oxytoca (929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella dysenteriae (933 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Listeria innocua (140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus gordonii (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clostridium perfringens (1165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas viridiflava (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Paenibacillus larvae (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella boydii (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella enterica subsp. enterica serovar Abony (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus brasiliensis (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus auricularis (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1c Voltage-gated L-type calcium channel alpha-1C subunit (1321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate (NMDA) receptor subunit zeta 1 (2166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gabra1 GABA receptor alpha-1 subunit (2848 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ptgs1 Cyclooxygenase-1 (1373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: YesChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: YesProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.44Molecular Weight (Monoisotopic): 444.1533AlogP: -0.21#Rotatable Bonds: 2
Polar Surface Area: 181.62Molecular Species: ZWITTERIONHBA: 9HBD: 6
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.91CX Basic pKa: 8.81CX LogP: -3.47CX LogD: -3.70
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: 1.70

References

1. Orme MW, Labroo VM.  (1994)  Synthesis of -estradiol-3-benzoate-17-(succinyl-12A-tetracycline): A potential bone-seeking estrogen,  (11): [10.1016/S0960-894X(01)80365-6]
2. Sum PE, Petersen P..  (1999)  Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.,  (10): [PMID:10360756] [10.1016/s0960-894x(99)00216-4]
3. Angehrn P, Buchmann S, Funk C, Goetschi E, Gmuender H, Hebeisen P, Kostrewa D, Link H, Luebbers T, Masciadri R, Nielsen J, Reindl P, Ricklin F, Schmitt-Hoffmann A, Theil FP..  (2004)  New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.,  47  (6): [PMID:14998336] [10.1021/jm0310232]
4. Sum PE, Lee VJ, Testa RT, Hlavka JJ, Ellestad GA, Bloom JD, Gluzman Y, Tally FP..  (1994)  Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.,  37  (1): [PMID:8289194] [10.1021/jm00027a023]
5. Coburn RA, Clark MT, Evans RT, Genco RJ..  (1987)  Substituted 2-(2-hydroxyphenyl)benzimidazoles as potential agents for the control of periodontal diseases.,  30  (1): [PMID:3806595] [10.1021/jm00384a035]
6. Galvez J, Gomez-Lechon M, Garcia-Domenech R, Castell J.  (1996)  New cytostatic agents obtained by molecular topology,  (19): [10.1016/0960-894X(96)00418-0]
7. Wright SW, Petraitis JJ, Abelman MM, Bostrom LL, Corbett RL, Green AM, Kindt RM, Sherk SR, Magolda RL.  (1993)  Inhibition of cartilage breakdown by isothiazolones,  (12): [10.1016/S0960-894X(01)80782-4]
8. Sol V, Branland P, Granet R, Kaldapa C, Verneuil B, Krausz P..  (1998)  Nitroglycosylated meso-arylporphyrins as photoinhibitors of gram positive bacteria.,  (21): [PMID:9873665] [10.1016/s0960-894x(98)00536-8]
9. Wright SW, Petraitis JJ, Abelman MM, Batt DG, Bostrom LL, Corbett RL, Decicco CP, Di Meo SV, Freimark B, Giannaras JV..  (1994)  Heteroaryl-fused 2-phenylisothiazolone inhibitors of cartilage breakdown.,  37  (19): [PMID:7932530] [10.1021/jm00045a012]
10. Allen NE, Alborn WE, Kirst HA, Toth JE..  (1987)  Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.,  30  (2): [PMID:3543366] [10.1021/jm00385a015]
11. Dominick PK, Keppler BR, Legassie JD, Moon IK, Jarstfer MB..  (2004)  Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.,  14  (13): [PMID:15177454] [10.1016/j.bmcl.2004.04.055]
12. Nelson ML, Park BH, Andrews JS, Georgian VA, Thomas RC, Levy SB..  (1993)  Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.,  36  (3): [PMID:8426364] [10.1021/jm00055a008]
13. Carcanague D, Shue YK, Wuonola MA, Uria-Nickelsen M, Joubran C, Abedi JK, Jones J, Kühler TC..  (2002)  Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.,  45  (19): [PMID:12213071] [10.1021/jm020868v]
14. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL..  (2001)  Cheminformatic models to predict binding affinities to human serum albumin.,  44  (25): [PMID:11728183] [10.1021/jm010960b]
15. Garcia-Domenech R, de Gregorio Alapont C, de Julian-Ortiz J, Galvez J, Popa L.  (1997)  Molecular connectivity to find -blockers with low toxicity,  (5): [10.1016/S0960-894X(97)00046-2]
16. Cox RJ, Schouten JA, Stentiford RA, Wareing KJ..  (1998)  Peptide inhibitors of N-succinyl diaminopimelic acid aminotransferase (DAP-AT): a novel class of antimicrobial compounds.,  (8): [PMID:9871517] [10.1016/s0960-894x(98)00149-8]
17. Ermondi G, Lorenti M, Caron G..  (2004)  Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction.,  47  (16): [PMID:15267234] [10.1021/jm040760a]
18. Liang CH, Romero A, Rabuka D, Sgarbi PW, Marby KA, Duffield J, Yao S, Cheng ML, Ichikawa Y, Sears P, Hu C, Hwang SB, Shue YK, Sucheck SJ..  (2005)  Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.,  15  (8): [PMID:15808482] [10.1016/j.bmcl.2005.02.029]
19. Nanjunda Swamy S, Basappa, Sarala G, Priya BS, Gaonkar SL, Shashidhara Prasad J, Rangappa KS..  (2006)  Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: antimicrobial studies.,  16  (4): [PMID:16298529] [10.1016/j.bmcl.2005.10.084]
20. Zhou Y, Sun Z, Froelich JM, Hermann T, Wall D..  (2006)  Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.,  16  (20): [PMID:16890435] [10.1016/j.bmcl.2006.07.052]
21. Leon A, Liu L, Yang Y, Hudock MP, Hall P, Yin F, Studer D, Puan KJ, Morita CT, Oldfield E..  (2006)  Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.,  49  (25): [PMID:17149863] [10.1021/jm060492b]
22. Epifano F, Menghini L, Pagiotti R, Angelini P, Genovese S, Curini M..  (2006)  In vitro inhibitory activity of boropinic acid against Helicobacter pylori.,  16  (21): [PMID:16945527] [10.1016/j.bmcl.2006.08.043]
23. Chen S, Cui S, McDermott PF, Zhao S, White DG, Paulsen I, Meng J..  (2007)  Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.,  51  (2): [PMID:17043131] [10.1128/aac.00600-06]
24. Ramya TN, Mishra S, Karmodiya K, Surolia N, Surolia A..  (2007)  Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.,  51  (1): [PMID:17060533] [10.1128/aac.00808-06]
25. Weigel LM, Donlan RM, Shin DH, Jensen B, Clark NC, McDougal LK, Zhu W, Musser KA, Thompson J, Kohlerschmidt D, Dumas N, Limberger RJ, Patel JB..  (2007)  High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.,  51  (1): [PMID:17074796] [10.1128/aac.00576-06]
26. Duewelhenke N, Krut O, Eysel P..  (2007)  Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.,  51  (1): [PMID:17088489] [10.1128/aac.00729-05]
27. Szumowski JD, Cohen DE, Kanaya F, Mayer KH..  (2007)  Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.,  51  (2): [PMID:17116664] [10.1128/aac.01244-06]
28. Frank KL, Reichert EJ, Piper KE, Patel R..  (2007)  In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.,  51  (3): [PMID:17158933] [10.1128/aac.01052-06]
29. Wolter N, Smith AM, Low DE, Klugman KP..  (2007)  High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.,  51  (3): [PMID:17210764] [10.1128/aac.01153-06]
30. Elkins CA, Mullis LB..  (2007)  Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.,  51  (3): [PMID:17210767] [10.1128/aac.01048-06]
31. Goswami M, Mangoli SH, Jawali N..  (2007)  Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.,  51  (3): [PMID:17210778] [10.1128/aac.00779-06]
32. Dean CR, Narayan S, Richards J, Daigle DM, Esterow S, Leeds JA, Kamp H, Puyang X, Wiedmann B, Mueller D, Voshol H, van Oostrum J, Wall D, Koehn J, Dzink-Fox J, Ryder NS..  (2007)  Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.,  51  (3): [PMID:17220413] [10.1128/aac.01103-06]
33. Izdebski R, Sadowy E, Fiett J, Grzesiowski P, Gniadkowski M, Hryniewicz W..  (2007)  Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.,  51  (4): [PMID:17210772] [10.1128/aac.01384-06]
34. Nicoloff H, Perreten V, Levy SB..  (2007)  Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.,  51  (4): [PMID:17220404] [10.1128/aac.01128-06]
35. Pucci MJ, Cheng J, Podos SD, Thoma CL, Thanassi JA, Buechter DD, Mushtaq G, Vigliotti GA, Bradbury BJ, Deshpande M..  (2007)  In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.,  51  (4): [PMID:17242152] [10.1128/aac.01315-06]
36. Brenciani A, Bacciaglia A, Vecchi M, Vitali LA, Varaldo PE, Giovanetti E..  (2007)  Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene.,  51  (4): [PMID:17261630] [10.1128/aac.01484-06]
37. Aghatabay NM, Neshat A, Karabiyik T, Somer M, Haciu D, Dülger B..  (2007)  Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.,  42  (2): [PMID:17189664] [10.1016/j.ejmech.2006.09.023]
38. Zhou Y, Gregor VE, Ayida BK, Winters GC, Sun Z, Murphy D, Haley G, Bailey D, Froelich JM, Fish S, Webber SE, Hermann T, Wall D..  (2007)  Synthesis and SAR of 3,5-diamino-piperidine derivatives: novel antibacterial translation inhibitors as aminoglycoside mimetics.,  17  (5): [PMID:17188860] [10.1016/j.bmcl.2006.12.024]
39. Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E..  (2007)  Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,  15  (6): [PMID:17267227] [10.1016/j.bmc.2007.01.026]
40. Tekiner-Gulbas B, Temiz-Arpaci O, Yildiz I, Altanlar N..  (2007)  Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.,  42  (10): [PMID:17337097] [10.1016/j.ejmech.2007.01.022]
41. Aghatabay NM, Somer M, Senel M, Dulger B, Gucin F..  (2007)  Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.,  42  (8): [PMID:17350734] [10.1016/j.ejmech.2007.01.011]
42. Villain-Guillot P, Gualtieri M, Bastide L, Roquet F, Martinez J, Amblard M, Pugniere M, Leonetti JP..  (2007)  Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.,  50  (17): [PMID:17665895] [10.1021/jm0703183]
43. Lv J, Qian Y, Liu T, Wang Y..  (2007)  Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.,  17  (15): [PMID:17570664] [10.1016/j.bmcl.2007.05.065]
44. Sriram D, Yogeeswari P, Senchani G, Banerjee D..  (2007)  Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.,  17  (8): [PMID:17376679] [10.1016/j.bmcl.2006.11.055]
45. Joshi MC, Bisht GS, Rawat DS..  (2007)  Syntheses and antibacterial activity of phendioxy substituted cyclic enediynes.,  17  (11): [PMID:17433674] [10.1016/j.bmcl.2007.03.007]
46. Bisht GS, Rawat DS, Kumar A, Kumar R, Pasha S..  (2007)  Antimicrobial activity of rationally designed amino terminal modified peptides.,  17  (15): [PMID:17553680] [10.1016/j.bmcl.2007.05.015]
47. Rajakumar P, Selvam S, Shanmugaiah V, Mathivanan N..  (2007)  Synthesis and antibacterial activity of some novel chiral fluorophoric biscyclic macrocycles.,  17  (18): [PMID:17689076] [10.1016/j.bmcl.2006.12.071]
48. Moda TL, Montanari CA, Andricopulo AD..  (2007)  Hologram QSAR model for the prediction of human oral bioavailability.,  15  (24): [PMID:17870541] [10.1016/j.bmc.2007.08.060]
49. Krasnoff SB, Keresztes I, Gillilan RE, Szebenyi DM, Donzelli BG, Churchill AC, Gibson DM..  (2007)  Serinocyclins A and B, cyclic heptapeptides from Metarhizium anisopliae.,  70  (12): [PMID:18044842] [10.1021/np070407i]
50. Prasad AK, Kumar P, Dhawan A, Chhillar AK, Sharma D, Yadav V, Kumar M, Jha HN, Olsen CE, Sharma GL, Parmar VS..  (2008)  Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols.,  18  (6): [PMID:18281215] [10.1016/j.bmcl.2008.01.080]
51. Vatmurge NS, Hazra BG, Pore VS, Shirazi F, Chavan PS, Deshpande MV..  (2008)  Synthesis and antimicrobial activity of beta-lactam-bile acid conjugates linked via triazole.,  18  (6): [PMID:18267360] [10.1016/j.bmcl.2008.01.102]
52. Knuckley B, Luo Y, Thompson PR..  (2008)  Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.,  16  (2): [PMID:17964793] [10.1016/j.bmc.2007.10.021]
53. Periyasami G, Raghunathan R, Surendiran G, Mathivanan N..  (2008)  Synthesis of novel spiropyrrolizidines as potent antimicrobial agents for human and plant pathogens.,  18  (7): [PMID:18342506] [10.1016/j.bmcl.2008.02.065]
54. Heller S, Kellenberger L, Shapiro S..  (2007)  Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.,  51  (6): [PMID:17387155] [10.1128/aac.00062-07]
55. Ayer V, Tewodros W, Manoharan A, Skariah S, Luo F, Bessen DE..  (2007)  Tetracycline resistance in group a streptococci: emergence on a global scale and influence on multiple-drug resistance.,  51  (5): [PMID:17307980] [10.1128/aac.01341-06]
56. Gentry DR, Rittenhouse SF, McCloskey L, Holmes DJ..  (2007)  Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.,  51  (6): [PMID:17404009] [10.1128/aac.01066-06]
57. Li Y, Zhang Y..  (2007)  PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.,  51  (6): [PMID:17420206] [10.1128/aac.00052-07]
58. Rantala M, Nyberg S, Lindgren M, Huovinen P, Jalava J, Skyttä R, Teirilä L, Vainio A, Virolainen-Julkunen A, Kaijalainen T..  (2007)  Molecular epidemiology of telithromycin-resistant pneumococci in Finland.,  51  (5): [PMID:17325224] [10.1128/aac.00187-07]
59. Kwon DH, Lu CD..  (2007)  Polyamine effects on antibiotic susceptibility in bacteria.,  51  (6): [PMID:17438056] [10.1128/aac.01472-06]
60. Llull D, Rivas L, García E..  (2007)  In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococci.,  51  (5): [PMID:17353242] [10.1128/aac.01428-06]
61. Zhou Y, Chow C, Murphy DE, Sun Z, Bertolini T, Froelich JM, Webber SE, Hermann T, Wall D..  (2008)  Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors.,  18  (11): [PMID:18440814] [10.1016/j.bmcl.2008.04.023]
62. Stierle DB, Stierle AA, Ganser B..  (1997)  New phomopsolides from a Penicillium sp.,  60  (11): [PMID:9392888] [10.1021/np970338f]
63. Kubec R, Kim S, McKeon DM, Musah RA..  (2002)  Isolation of S-n-butylcysteine sulfoxide and six n-butyl-containing thiosulfinates from Allium siculum.,  65  (7): [PMID:12141853] [10.1021/np020064i]
64. Zhang W, Krohn K, Draeger S, Schulz B..  (2008)  Bioactive isocoumarins isolated from the endophytic fungus Microdochium bolleyi.,  71  (6): [PMID:18510362] [10.1021/np800095g]
65. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F..  (2008)  Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.,  51  (21): [PMID:18834112] [10.1021/jm800656v]
66. Aghatabay NM, Mahmiani Y, Cevik H, Dulger B..  (2009)  Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.,  44  (1): [PMID:18417256] [10.1016/j.ejmech.2008.02.038]
67. Periyasami G, Raghunathan R, Surendiran G, Mathivanan N..  (2009)  Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.,  44  (3): [PMID:18722036] [10.1016/j.ejmech.2008.07.009]
68. Rupprecht JK, Hui YH, McLaughlin JL..  (1990)  Annonaceous acetogenins: a review.,  53  (2): [PMID:2199608] [10.1021/np50068a001]
69. Sapunaric FM, Levy SB..  (2007)  Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.,  51  (8): [PMID:17517833] [10.1128/aac.00357-07]
70. Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, Gotuzzo E, Kronvall G, Paradisi F, Rossolini GM..  (2007)  Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America.,  51  (8): [PMID:17548490] [10.1128/aac.00026-07]
71. Meehl M, Herbert S, Götz F, Cheung A..  (2007)  Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.,  51  (8): [PMID:17502406] [10.1128/aac.00209-07]
72. Ikonomidis A, Labrou M, Afkou Z, Maniatis AN, Sofianou D, Tsakris A, Pournaras S..  (2007)  First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.,  51  (8): [PMID:17517838] [10.1128/aac.00374-07]
73. Chen YT, Lauderdale TL, Liao TL, Shiau YR, Shu HY, Wu KM, Yan JJ, Su IJ, Tsai SF..  (2007)  Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.,  51  (8): [PMID:17526756] [10.1128/aac.00167-07]
74. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P..  (2008)  Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.,  51  (19): [PMID:18788725] [10.1021/jm8003152]
75. Neale JR, Richter NB, Merten KE, Taylor KG, Singh S, Waite LC, Emery NK, Smith NB, Cai J, Pierce WM..  (2009)  Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent.,  19  (3): [PMID:19117754] [10.1016/j.bmcl.2008.12.051]
76. Pereda-Miranda R, Kaatz GW, Gibbons S..  (2006)  Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.,  69  (3): [PMID:16562846] [10.1021/np050227d]
77. Hu JF, Garo E, Hough GW, Goering MG, O'Neil-Johnson M, Eldridge GR..  (2006)  Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.,  69  (4): [PMID:16643031] [10.1021/np050438i]
78. Krasnoff SB, Reátegui RF, Wagenaar MM, Gloer JB, Gibson DM..  (2005)  Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda.,  68  (1): [PMID:15679316] [10.1021/np0497189]
79. Findlay JA, Patil AD..  (1984)  Antibacterial constituents of the diatom Navicula delognei.,  47  (5): [PMID:6512534] [10.1021/np50035a010]
80. Sidhu AB, Sun Q, Nkrumah LJ, Dunne MW, Sacchettini JC, Fidock DA..  (2007)  In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.,  282  (4): [PMID:17110371] [10.1074/jbc.m608615200]
81. Muhammad I, Li XC, Dunbar DC, ElSohly MA, Khan IA..  (2001)  Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum.,  64  (10): [PMID:11678659] [10.1021/np0102861]
82. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P..  (2008)  Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).,  51  (11): [PMID:18457386] [10.1021/jm7015683]
83. Rajakumar P, Sekar K, Shanmugaiah V, Mathivanan N..  (2008)  Synthesis of some novel imidazole-based dicationic carbazolophanes as potential antibacterials.,  18  (15): [PMID:18620857] [10.1016/j.bmcl.2008.06.047]
84. Bavikar SN, Salunke DB, Hazra BG, Pore VS, Dodd RH, Thierry J, Shirazi F, Deshpande MV, Kadreppa S, Chattopadhyay S..  (2008)  Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.,  18  (20): [PMID:18805690] [10.1016/j.bmcl.2008.09.013]
85. Bazgir A, Khanaposhtani MM, Soorki AA..  (2008)  One-pot synthesis and antibacterial activities of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine-dione derivatives.,  18  (21): [PMID:18842404] [10.1016/j.bmcl.2008.09.057]
86. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, Shibayama K, Konda T, Arakawa Y..  (2007)  New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.,  51  (9): [PMID:17548499] [10.1128/aac.00339-07]
87. Tuckman M, Petersen PJ, Howe AY, Orlowski M, Mullen S, Chan K, Bradford PA, Jones CH..  (2007)  Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.,  51  (9): [PMID:17620376] [10.1128/aac.00625-07]
88. Calatayud L, Ardanuy C, Cercenado E, Fenoll A, Bouza E, Pallares R, Martín R, Liñares J..  (2007)  Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.,  51  (9): [PMID:17606677] [10.1128/aac.00157-07]
89. Gibreel A, Wetsch NM, Taylor DE..  (2007)  Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.,  51  (9): [PMID:17606685] [10.1128/aac.01592-06]
90. Pérez A, Canle D, Latasa C, Poza M, Beceiro A, Tomás Mdel M, Fernández A, Mallo S, Pérez S, Molina F, Villanueva R, Lasa I, Bou G..  (2007)  Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.,  51  (9): [PMID:17638702] [10.1128/aac.00072-07]
91. Jansen WT, Verel A, Verhoef J, Milatovic D..  (2007)  In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.,  51  (9): [PMID:17606689] [10.1128/aac.00100-07]
92. Beena, Kumar N, Rohilla RK, Roy N, Roy N, Rawat DS..  (2009)  Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates.,  19  (5): [PMID:19195884] [10.1016/j.bmcl.2009.01.037]
93. Lv PC, Xiao ZP, Fang RQ, Li HQ, Zhu HL, Liu CH..  (2009)  Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.,  44  (4): [PMID:18539361] [10.1016/j.ejmech.2008.04.019]
94. Simor AE, Stuart TL, Louie L, Watt C, Ofner-Agostini M, Gravel D, Mulvey M, Loeb M, McGeer A, Bryce E, Matlow A, Canadian Nosocomial Infection Surveillance Program..  (2007)  Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.,  51  (11): [PMID:17724154] [10.1128/aac.00846-07]
95. Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D, Clements D, Tang H, Scott RW, Tew GN, Diamond G..  (2007)  Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens.,  51  (11): [PMID:17785509] [10.1128/aac.00208-07]
96. Baqi Y, Atzler K, Köse M, Glänzel M, Müller CE..  (2009)  High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.,  52  (12): [PMID:19463000] [10.1021/jm9003297]
97. Jaki B, Orjala J, Heilmann J, Linden A, Vogler B, Sticher O..  (2000)  Novel extracellular diterpenoids with biological activity from the cyanobacterium Nostoc commune.,  63  (3): [PMID:10757714] [10.1021/np9903090]
98. Socha AM, Garcia D, Sheffer R, Rowley DC..  (2006)  Antibiotic bisanthraquinones produced by a streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata.,  69  (7): [PMID:16872146] [10.1021/np050449b]
99. Hamburger MO, Cordell GA, Tantivatana P, Ruangrungsi N..  (1987)  Traditional medicinal plants of Thailand, VIII. Isoflavonoids of Dalbergia candenatensis.,  50  (4): [PMID:3430167] [10.1021/np50052a020]
100. Plasencia V, Borrell N, Maciá MD, Moya B, Pérez JL, Oliver A..  (2007)  Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.,  51  (7): [PMID:17470655] [10.1128/aac.00174-07]
101. Cenizal MJ, Skiest D, Luber S, Bedimo R, Davis P, Fox P, Delaney K, Hardy RD..  (2007)  Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus.,  51  (7): [PMID:17502411] [10.1128/aac.00206-07]
102. Shin JH, Jung HJ, Kim HR, Jeong J, Jeong SH, Kim S, Lee EY, Lee JN, Chang CL..  (2007)  Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.,  51  (7): [PMID:17502407] [10.1128/aac.00107-07]
103. Périchon B, Courvalin P, Galimand M..  (2007)  Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.,  51  (7): [PMID:17470656] [10.1128/aac.00143-07]
104. Yum JH, Kim CK, Yong D, Lee K, Chong Y, Kim CM, Kim JM, Ro S, Cho JM..  (2007)  In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.,  51  (7): [PMID:17420210] [10.1128/aac.01562-06]
105. Power P, Di Conza J, Rodríguez MM, Ghiglione B, Ayala JA, Casellas JM, Radice M, Gutkind G..  (2007)  Biochemical characterization of PER-2 and genetic environment of blaPER-2.,  51  (7): [PMID:17438050] [10.1128/aac.01395-06]
106. Chow VC, Hawkey PM, Chan EW, Chin ML, Au TK, Fung DK, Chan RC..  (2007)  High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.,  51  (7): [PMID:17371822] [10.1128/aac.00603-06]
107. Chérigo L, Pereda-Miranda R, Fragoso-Serrano M, Jacobo-Herrera N, Kaatz GW, Gibbons S..  (2008)  Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.,  71  (6): [PMID:18500841] [10.1021/np800148w]
108. Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M, Smith E, Rahman MM..  (2008)  Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.,  71  (8): [PMID:18681481] [10.1021/np8002673]
109. Avila HP, Smânia Ede F, Monache FD, Smânia A..  (2008)  Structure-activity relationship of antibacterial chalcones.,  16  (22): [PMID:18951808] [10.1016/j.bmc.2008.09.064]
110. Kandile NG, Mohamed MI, Zaky H, Mohamed HM..  (2009)  Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation.,  44  (5): [PMID:19013692] [10.1016/j.ejmech.2008.09.047]
111. Kindrachuk J, Paur N, Reiman C, Scruten E, Napper S..  (2007)  The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance.,  51  (12): [PMID:17938183] [10.1128/aac.00854-07]
112. van Hoek AH, Mayrhofer S, Domig KJ, Flórez AB, Ammor MS, Mayo B, Aarts HJ..  (2008)  Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.,  52  (1): [PMID:17967912] [10.1128/aac.00714-07]
113. Subramanian S, Roberts CL, Hart CA, Martin HM, Edwards SW, Rhodes JM, Campbell BJ..  (2008)  Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.,  52  (2): [PMID:18070962] [10.1128/aac.00375-07]
114. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A..  (2009)  Physicochemical determinants of human renal clearance.,  52  (15): [PMID:19445515] [10.1021/jm900403j]
115. Rajakumar P, Sekar K, Shanmugaiah V, Mathivanan N..  (2009)  Synthesis of novel carbazole based macrocyclic amides as potential antimicrobial agents.,  44  (7): [PMID:18778877] [10.1016/j.ejmech.2008.07.031]
116. Wolter N, Smith AM, Farrell DJ, Northwood JB, Douthwaite S, Klugman KP..  (2008)  Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.,  52  (2): [PMID:18056269] [10.1128/aac.01074-07]
117. Castanheira M, Sader HS, Deshpande LM, Fritsche TR, Jones RN..  (2008)  Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.,  52  (2): [PMID:18070960] [10.1128/aac.01114-07]
118. Damier-Piolle L, Magnet S, Brémont S, Lambert T, Courvalin P..  (2008)  AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.,  52  (2): [PMID:18086852] [10.1128/aac.00732-07]
119. Spigaglia P, Barbanti F, Mastrantonio P..  (2008)  Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile.,  52  (2): [PMID:18070963] [10.1128/aac.00957-07]
120. Del Grosso M, Northwood JG, Farrell DJ, Pantosti A..  (2007)  The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271.,  51  (11): [PMID:17709465] [10.1128/aac.00598-07]
121. Dégrange S, Renaudin H, Charron A, Bébéar C, Bébéar CM..  (2008)  Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines.,  52  (2): [PMID:18025113] [10.1128/aac.00960-07]
122. Stavri M, Paton A, Skelton BW, Gibbons S..  (2009)  Antibacterial diterpenes from Plectranthus ernstii.,  72  (6): [PMID:19445517] [10.1021/np800581s]
123. Sieradzki K, Chung M, Tomasz A..  (2008)  Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.,  52  (2): [PMID:18056270] [10.1128/aac.00504-07]
124. Farag NA, El-Tayeb W..  (2010)  Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents.,  45  (1): [PMID:19897282] [10.1016/j.ejmech.2009.10.016]
125. Ahmad M, Siddiqui HL, Zia-ur-Rehman M, Parvez M..  (2010)  Anti-oxidant and anti-bacterial activities of novel N'-arylmethylidene-2-(3, 4-dimethyl-5, 5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-2(4H)-yl) acetohydrazides.,  45  (2): [PMID:19962218] [10.1016/j.ejmech.2009.11.016]
126. Aghatabay NM, Baş A, Kircali A, Sen G, Yazicioğlu MB, Gücin F, Dülger B..  (2009)  Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.,  44  (11): [PMID:19700225] [10.1016/j.ejmech.2009.07.003]
127. El-Sayed Ali T..  (2009)  Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.,  44  (11): [PMID:19586688] [10.1016/j.ejmech.2009.05.031]
128. Ali Tel-S..  (2009)  Synthesis and antibacterial activity of some new thiadiaza/triazaphospholes, thiadiaza/triaza/tetrazaphosphinines and thiadiaza/tetrazaphosphepines containing 1,2,4-triazinone moiety.,  44  (11): [PMID:19615792] [10.1016/j.ejmech.2009.06.022]
129. Tam KY, Avdeef A, Tsinman O, Sun N..  (2010)  The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.,  53  (1): [PMID:19947605] [10.1021/jm901421c]
130. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD..  (2010)  Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.,  53  (3): [PMID:20070106] [10.1021/jm901371v]
131. Bandgar BP, Gawande SS, Bodade RG, Gawande NM, Khobragade CN..  (2009)  Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.,  17  (24): [PMID:19896853] [10.1016/j.bmc.2009.10.035]
132. Huigens RW, Reyes S, Reed CS, Bunders C, Rogers SA, Steinhauer AT, Melander C..  (2010)  The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.,  18  (2): [PMID:20044260] [10.1016/j.bmc.2009.12.003]
133. Kumar D, Joshi S, Rohilla RK, Roy N, Roy N, Rawat DS..  (2010)  Synthesis and antibacterial activity of benzyl-[3-(benzylamino-methyl)-cyclohexylmethyl]-amine derivatives.,  20  (3): [PMID:20047831] [10.1016/j.bmcl.2009.12.074]
134. Bandgar BP, Gawande SS..  (2010)  Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.,  18  (5): [PMID:20138527] [10.1016/j.bmc.2009.12.077]
135. Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu G..  (2009)  Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.,  44  (11): [PMID:19616347] [10.1016/j.ejmech.2009.06.021]
136. Reinke AA, Seh HY, Gestwicki JE..  (2009)  A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.,  19  (17): [PMID:19640715] [10.1016/j.bmcl.2009.07.082]
137. Dawane BS, Konda SG, Mandawad GG, Shaikh BM..  (2010)  Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4'-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation.,  45  (1): [PMID:19896247] [10.1016/j.ejmech.2009.10.015]
138. Khobragade CN, Bodade RG, Konda SG, Dawane BS, Manwar AV..  (2010)  Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.,  45  (4): [PMID:20096486] [10.1016/j.ejmech.2009.12.040]
139. Opperman TJ, Williams JD, Houseweart C, Panchal RG, Bavari S, Peet NP, Moir DT, Bowlin TL..  (2010)  Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.,  18  (6): [PMID:20188576] [10.1016/j.bmc.2010.02.005]
140. Arumugam N, Raghunathan R, Shanmugaiah V, Mathivanan N..  (2010)  Synthesis of novel beta-lactam fused spiroisoxazolidine chromanones and tetralones as potent antimicrobial agent for human and plant pathogens.,  20  (12): [PMID:20483609] [10.1016/j.bmcl.2010.04.084]
141. Almajan GL, Barbuceanu SF, Saramet I, Draghici C..  (2010)  New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.,  45  (7): [PMID:20307919] [10.1016/j.ejmech.2010.02.057]
142. Schneemann I, Kajahn I, Ohlendorf B, Zinecker H, Erhard A, Nagel K, Wiese J, Imhoff JF..  (2010)  Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea.,  73  (7): [PMID:20545334] [10.1021/np100135b]
143. Karthikeyan K, Sivakumar PM, Doble M, Perumal PT..  (2010)  Synthesis, antibacterial activity evaluation and QSAR studies of novel dispiropyrrolidines.,  45  (8): [PMID:20556891] [10.1016/j.ejmech.2010.04.035]
144. Faure S, Perrin-Guyomard A, Delmas JM, Chatre P, Laurentie M..  (2010)  Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.,  54  (1): [PMID:19901088] [10.1128/aac.00310-09]
145. Coyne S, Guigon G, Courvalin P, Périchon B..  (2010)  Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.,  54  (1): [PMID:19884373] [10.1128/aac.01037-09]
146. Kim HB, Wang M, Ahmed S, Park CH, LaRocque RC, Faruque AS, Salam MA, Khan WA, Qadri F, Calderwood SB, Jacoby GA, Hooper DC..  (2010)  Transferable quinolone resistance in Vibrio cholerae.,  54  (2): [PMID:19949057] [10.1128/aac.01045-09]
147. Padilla E, Llobet E, Doménech-Sánchez A, Martínez-Martínez L, Bengoechea JA, Albertí S..  (2010)  Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.,  54  (1): [PMID:19858254] [10.1128/aac.00715-09]
148. Montes M, Tamayo E, Orden B, Larruskain J, Perez-Trallero E..  (2010)  Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.,  54  (1): [PMID:19805559] [10.1128/aac.00780-09]
149. Prado-Prado FJ, García-Mera X, González-Díaz H..  (2010)  Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.,  18  (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068]
150. Melchiorre C, Bolognesi ML, Minarini A, Rosini M, Tumiatti V..  (2010)  Polyamines in drug discovery: from the universal template approach to the multitarget-directed ligand design strategy.,  53  (16): [PMID:20420456] [10.1021/jm100293f]
151. Radulović N, Denić M, Stojanović-Radić Z..  (2010)  Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae).,  20  (17): [PMID:20674349] [10.1016/j.bmcl.2010.07.063]
152. Hood MI, Jacobs AC, Sayood K, Dunman PM, Skaar EP..  (2010)  Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.,  54  (3): [PMID:20028819] [10.1128/aac.00963-09]
153. Elkins CA, Mullis LB, Lacher DW, Jung CM..  (2010)  Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.,  54  (3): [PMID:20038628] [10.1128/aac.01126-09]
154. O'Regan E, Quinn T, Frye JG, Pagès JM, Porwollik S, Fedorka-Cray PJ, McClelland M, Fanning S..  (2010)  Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.,  54  (1): [PMID:19917752] [10.1128/aac.00801-09]
155. Kadlec K, Schwarz S..  (2010)  Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.,  54  (2): [PMID:20008780] [10.1128/aac.01091-09]
156. Sader HS, Fritsche TR, Jones RN..  (2008)  Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.,  52  (3): [PMID:18180353] [10.1128/aac.01351-07]
157. Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN..  (2008)  First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.,  52  (6): [PMID:18391032] [10.1128/aac.00231-08]
158. Fàbrega A, Martin RG, Rosner JL, Tavio MM, Vila J..  (2010)  Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.,  54  (3): [PMID:20008776] [10.1128/aac.00944-09]
159. Lehtopolku M, Nakari UM, Kotilainen P, Huovinen P, Siitonen A, Hakanen AJ..  (2010)  Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.,  54  (3): [PMID:20038624] [10.1128/aac.00898-09]
160. de la Pedrosa EG, Morosini MI, van der Linden M, Ruiz-Garbajosa P, Galán JC, Baquero F, Reinert RR, Cantón R..  (2008)  Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).,  52  (6): [PMID:18362188] [10.1128/aac.01487-07]
161. Ilina EN, Vereshchagin VA, Borovskaya AD, Malakhova MV, Sidorenko SV, Al-Khafaji NC, Kubanova AA, Govorun VM..  (2008)  Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.,  52  (6): [PMID:18378705] [10.1128/aac.01420-07]
162. Urich SK, Petersen JM..  (2008)  In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.,  52  (6): [PMID:18411318] [10.1128/aac.01584-07]
163. Salas C, Calvo J, Martínez-Martínez L..  (2008)  Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.,  52  (4): [PMID:18227183] [10.1128/aac.01129-07]
164. Blango MG, Mulvey MA..  (2010)  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.,  54  (5): [PMID:20231390] [10.1128/aac.00014-10]
165. Cochetti I, Tili E, Mingoia M, Varaldo PE, Montanari MP..  (2008)  erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003.,  52  (4): [PMID:18285489] [10.1128/aac.01457-07]
166. Bortolaia V, Guardabassi L, Trevisani M, Bisgaard M, Venturi L, Bojesen AM..  (2010)  High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates from Italian broiler flocks.,  54  (4): [PMID:20100875] [10.1128/aac.01361-09]
167. Miller K, O'Neill AJ, Wilcox MH, Ingham E, Chopra I..  (2008)  Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.,  52  (6): [PMID:18378719] [10.1128/aac.01302-07]
168. Mendes RE, Moet GJ, Janechek MJ, Jones RN..  (2010)  In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.,  54  (6): [PMID:20385851] [10.1128/aac.00301-10]
169. Jiang SS, Liu MC, Teng LJ, Wang WB, Hsueh PR, Liaw SJ..  (2010)  Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.,  54  (4): [PMID:20123999] [10.1128/aac.01219-09]
170. Gill SC, Rubino CM, Bassett J, Miller L, Ambrose PG, Bhavnani SM, Beaudry A, Li J, Stone KC, Critchley I, Janjic N, Heine HS..  (2010)  Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.,  54  (5): [PMID:20145081] [10.1128/aac.00737-08]
171. Khalil H, Chen T, Riffon R, Wang R, Wang Z..  (2008)  Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.,  52  (5): [PMID:18285485] [10.1128/aac.01071-07]
172. Ressner RA, Griffith ME, Beckius ML, Pimentel G, Miller RS, Mende K, Fraser SL, Galloway RL, Hospenthal DR, Murray CK..  (2008)  Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.,  52  (8): [PMID:18411316] [10.1128/aac.00044-08]
173. Krause KM, Renelli M, Difuntorum S, Wu TX, Debabov DV, Benton BM..  (2008)  In vitro activity of telavancin against resistant gram-positive bacteria.,  52  (7): [PMID:18443122] [10.1128/aac.01398-07]
174. Kedar GC, Brown-Driver V, Reyes DR, Hilgers MT, Stidham MA, Shaw KJ, Finn J, Haselbeck RJ..  (2008)  Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.,  52  (6): [PMID:18378720] [10.1128/aac.01594-07]
175. Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P..  (2008)  Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.,  52  (8): [PMID:18519712] [10.1128/aac.01672-07]
176. Danilchanka O, Mailaender C, Niederweis M..  (2008)  Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.,  52  (7): [PMID:18458127] [10.1128/aac.00298-08]
177. Schwaiger K, Bauer J..  (2008)  Detection of the erythromycin rRNA methylase gene erm(A) in Enterococcus faecalis.,  52  (8): [PMID:18505854] [10.1128/aac.00230-08]
178. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P..  (2008)  Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.,  52  (8): [PMID:18505851] [10.1128/aac.00171-08]
179. Miller AA, Bundy GL, Mott JE, Skepner JE, Boyle TP, Harris DW, Hromockyj AE, Marotti KR, Zurenko GE, Munzner JB, Sweeney MT, Bammert GF, Hamel JC, Ford CW, Zhong WZ, Graber DR, Martin GE, Han F, Dolak LA, Seest EP, Ruble JC, Kamilar GM, Palmer JR, Banitt LS, Hurd AR, Barbachyn MR..  (2008)  Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.,  52  (8): [PMID:18519725] [10.1128/aac.00247-08]
180. Pränting M, Negrea A, Rhen M, Andersson DI..  (2008)  Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.,  52  (8): [PMID:18519732] [10.1128/aac.00205-08]
181. Steidl R, Pearson S, Stephenson RE, Ledala N, Sitthisak S, Wilkinson BJ, Jayaswal RK..  (2008)  Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials.,  52  (8): [PMID:18541730] [10.1128/aac.00273-08]
182. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM..  (2008)  Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.,  52  (10): [PMID:18644962] [10.1128/aac.00582-08]
183. Mima T, Schweizer HP..  (2010)  The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.,  54  (8): [PMID:20498323] [10.1128/aac.01803-09]
184. Gaudreau C, Girouard Y, Gilbert H, Gagnon J, Bekal S..  (2008)  Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni.,  52  (12): [PMID:18838597] [10.1128/aac.00767-08]
185. Pires R, Ardanuy C, Rolo D, Morais A, Brito-Avô A, Gonçalo-Marques J, Liñares J, Santos-Sanches I..  (2010)  Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.,  54  (6): [PMID:20350943] [10.1128/aac.01536-09]
186. Sugimura M, Maseda H, Hanaki H, Nakae T..  (2008)  Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.,  52  (11): [PMID:18676884] [10.1128/aac.00511-08]
187. Bailey AM, Paulsen IT, Piddock LJ..  (2008)  RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.,  52  (10): [PMID:18694955] [10.1128/aac.00661-08]
188. Kazimierczak KA, Rincon MT, Patterson AJ, Martin JC, Young P, Flint HJ, Scott KP..  (2008)  A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.,  52  (11): [PMID:18779355] [10.1128/aac.00308-08]
189. Zhang T, Bishai WR, Grosset JH, Nuermberger EL..  (2010)  Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.,  54  (7): [PMID:20421401] [10.1128/aac.00400-10]
190. Abril C, Brodard I, Perreten V..  (2010)  Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.,  54  (7): [PMID:20479200] [10.1128/aac.00304-10]
191. Waites KB, Crabb DM, Duffy LB..  (2008)  Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.,  52  (10): [PMID:18663020] [10.1128/aac.00849-08]
192. Cattoir V, Poirel L, Nordmann P..  (2008)  Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.,  52  (10): [PMID:18644958] [10.1128/aac.00638-08]
193. Gentry DR, McCloskey L, Gwynn MN, Rittenhouse SF, Scangarella N, Shawar R, Holmes DJ..  (2008)  Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus.,  52  (12): [PMID:18838584] [10.1128/aac.00915-08]
194. Rodríguez MM, Power P, Sader H, Galleni M, Gutkind G..  (2010)  Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.,  54  (7): [PMID:20421403] [10.1128/aac.01615-09]
195. Goswami M, Jawali N..  (2010)  N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.,  54  (8): [PMID:20547812] [10.1128/aac.00710-10]
196. McCalla C, Smyth DS, Robinson DA, Steenbergen J, Luperchio SA, Moise PA, Fowler VG, Sakoulas G..  (2008)  Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.,  52  (9): [PMID:18606839] [10.1128/aac.00357-08]
197. Bucki R, Leszczynska K, Byfield FJ, Fein DE, Won E, Cruz K, Namiot A, Kulakowska A, Namiot Z, Savage PB, Diamond SL, Janmey PA..  (2010)  Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.,  54  (6): [PMID:20308375] [10.1128/aac.01682-09]
198. Nagano N, Nagano Y, Kimura K, Tamai K, Yanagisawa H, Arakawa Y..  (2008)  Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.,  52  (12): [PMID:18809936] [10.1128/aac.00596-08]
199. Hilmy KM, Khalifa MM, Hawata MA, Keshk RM, el-Torgman AA..  (2010)  Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents.,  45  (11): [PMID:20828885] [10.1016/j.ejmech.2010.08.043]
200. Nasim S, Vartak AP, Pierce WM, Taylor KG, Smith N, Crooks PA..  (2010)  3-O-phosphate ester conjugates of 17-β-O-{1-[2-carboxy-(2-hydroxy-4-methoxy-3-carboxamido)anilido]ethyl}1,3,5(10)-estratriene as novel bone-targeting agents.,  20  (24): [PMID:21055931] [10.1016/j.bmcl.2010.10.023]
201. Purushothaman S, Prasanna R, Niranjana P, Raghunathan R, Nagaraj S, Rengasamy R..  (2010)  Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens.,  20  (24): [PMID:21067922] [10.1016/j.bmcl.2010.10.073]
202. PubChem BioAssay data set, 
203. Obach RS, Lombardo F, Waters NJ..  (2008)  Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.,  36  (7): [PMID:18426954] [10.1124/dmd.108.020479]
204. Castanheira M, Bell JM, Turnidge JD, Mathai D, Jones RN..  (2009)  Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).,  53  (3): [PMID:19114677] [10.1128/aac.01011-08]
205. Cui L, Neoh HM, Shoji M, Hiramatsu K..  (2009)  Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.,  53  (3): [PMID:19124662] [10.1128/aac.01173-08]
206. Biedenbach DJ, Bell JM, Sader HS, Turnidge JD, Jones RN..  (2009)  Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.,  53  (3): [PMID:19124664] [10.1128/aac.01453-08]
207. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM, Jones RN..  (2009)  Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.,  53  (2): [PMID:19015330] [10.1128/aac.00999-08]
208. Kadlec K, Schwarz S..  (2009)  Identification of a novel trimethoprim resistance gene, dfrK, in a methicillin-resistant Staphylococcus aureus ST398 strain and its physical linkage to the tetracycline resistance gene tet(L).,  53  (2): [PMID:19015335] [10.1128/aac.01128-08]
209. Welch TJ, Evenhuis J, White DG, McDermott PF, Harbottle H, Miller RA, Griffin M, Wise D..  (2009)  IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.,  53  (2): [PMID:19029319] [10.1128/aac.01312-08]
210. Liu CY, Huang YT, Liao CH, Hsueh PR..  (2008)  In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.,  52  (7): [PMID:18474585] [10.1128/aac.00002-08]
211. Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG..  (2010)  Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.,  54  (7): [PMID:20404127] [10.1128/aac.01845-09]
212. Zheng B, Tomita H, Inoue T, Ike Y..  (2009)  Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2201, encoding erythromycin resistance and cytolysin (Hly/Bac).,  53  (2): [PMID:19029325] [10.1128/aac.00754-08]
213. Liu Y, Wang H, Du N, Shen E, Chen H, Niu J, Ye H, Chen M..  (2009)  Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.,  53  (2): [PMID:19029328] [10.1128/aac.00804-08]
214. Kehrenberg C, Cuny C, Strommenger B, Schwarz S, Witte W..  (2009)  Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr.,  53  (2): [PMID:19047652] [10.1128/aac.01376-08]
215. Byrne-Bailey KG, Gaze WH, Kay P, Boxall AB, Hawkey PM, Wellington EM..  (2009)  Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom.,  53  (2): [PMID:19064898] [10.1128/aac.00652-07]
216. Del Grosso M, Camilli R, Libisch B, Füzi M, Pantosti A..  (2009)  New composite genetic element of the Tn916 family with dual macrolide resistance genes in a Streptococcus pneumoniae isolate belonging to clonal complex 271.,  53  (3): [PMID:19104015] [10.1128/aac.01066-08]
217. O'Regan E, Quinn T, Pagès JM, McCusker M, Piddock L, Fanning S..  (2009)  Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.,  53  (3): [PMID:19104017] [10.1128/aac.01005-08]
218. Wang G, Inaoka T, Okamoto S, Ochi K..  (2009)  A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.,  53  (3): [PMID:19104019] [10.1128/aac.00388-08]
219. Kadlec K, Schwarz S..  (2010)  Identification of the novel dfrK-carrying transposon Tn559 in a porcine methicillin-susceptible Staphylococcus aureus ST398 strain.,  54  (8): [PMID:20498309] [10.1128/aac.00464-10]
220. San Millan A, Escudero JA, Gutierrez B, Hidalgo L, Garcia N, Llagostera M, Dominguez L, Gonzalez-Zorn B..  (2009)  Multiresistance in Pasteurella multocida is mediated by coexistence of small plasmids.,  53  (8): [PMID:19528282] [10.1128/aac.01522-08]
221. Alvarez A, Moncayo JI, Santacruz JJ, Santacoloma M, Corredor LF, Reinosa E..  (2009)  Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.,  53  (9): [PMID:19546360] [10.1128/aac.00145-09]
222. Kurokawa K, Hamamoto H, Matsuo M, Nishida S, Yamane N, Lee BL, Murakami K, Maki H, Sekimizu K..  (2009)  Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.,  53  (9): [PMID:19546371] [10.1128/aac.00200-09]
223. Roca I, Marti S, Espinal P, Martínez P, Gibert I, Vila J..  (2009)  CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.,  53  (9): [PMID:19581458] [10.1128/aac.00584-09]
224. Svetlíková Z, Skovierová H, Niederweis M, Gaillard JL, McDonnell G, Jackson M..  (2009)  Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.,  53  (9): [PMID:19581465] [10.1128/aac.00590-09]
225. Ahmed NA, Petersen FC, Scheie AA..  (2009)  AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.,  53  (10): [PMID:19596873] [10.1128/aac.00546-09]
226. Baraniak A, Izdebski R, Herda M, Fiett J, Hryniewicz W, Gniadkowski M, Kern-Zdanowicz I, Filczak K, Łopaciuk U..  (2009)  Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.,  53  (10): [PMID:19620323] [10.1128/aac.00436-09]
227. Rukayadi Y, Lee K, Han S, Yong D, Hwang JK..  (2009)  In vitro activities of panduratin A against clinical Staphylococcus strains.,  53  (10): [PMID:19651906] [10.1128/aac.00624-09]
228. Suchland RJ, Sandoz KM, Jeffrey BM, Stamm WE, Rockey DD..  (2009)  Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.,  53  (11): [PMID:19687238] [10.1128/aac.00477-09]
229. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM..  (2009)  Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.,  53  (10): [PMID:19687243] [10.1128/aac.00688-09]
230. Duval V, Nicoloff H, Levy SB..  (2009)  Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.,  53  (11): [PMID:19721064] [10.1128/aac.00787-09]
231. Duval V, Maiga I, Maiga A, Guillard T, Brasme L, Forte D, Madoux J, Vernet-Garnier V, De Champs C..  (2009)  High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.,  53  (11): [PMID:19721071] [10.1128/aac.00675-09]
232. Rao SS, Raghunathan R, Ekambaram R, Raghunathan M..  (2009)  In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.,  53  (12): [PMID:19738013] [10.1128/aac.00746-09]
233. Hamasuna R, Jensen JS, Osada Y..  (2009)  Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR.,  53  (11): [PMID:19738019] [10.1128/aac.00724-09]
234. Maseda H, Hashida Y, Konaka R, Shirai A, Kourai H..  (2009)  Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.,  53  (12): [PMID:19752278] [10.1128/aac.00631-09]
235. Miller CH, Nisa S, Dempsey S, Jack C, O'Toole R..  (2009)  Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.,  53  (12): [PMID:19786608] [10.1128/aac.00803-09]
236. Dai L, Wu CM, Wang MG, Wang Y, Wang Y, Huang SY, Xia LN, Li BB, Shen JZ..  (2010)  First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.,  54  (9): [PMID:20585133] [10.1128/aac.00169-10]
237. Jones RN, Biedenbach DJ, Roblin PM, Kohlhoff SA, Hammerschlag MR..  (2010)  Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.,  54  (10): [PMID:20660671] [10.1128/aac.00235-10]
238. Tran QT, Dupont M, Lavigne JP, Chevalier J, Pagès JM, Sotto A, Davin-Regli A..  (2009)  Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.,  53  (4): [PMID:19164140] [10.1128/aac.00822-08]
239. Hedberg ST, Fredlund H, Nicolas P, Caugant DA, Olcén P, Unemo M..  (2009)  Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.,  53  (4): [PMID:19188396] [10.1128/aac.00994-08]
240. Blackman Northwood J, Del Grosso M, Cossins LR, Coley MD, Creti R, Pantosti A, Farrell DJ..  (2009)  Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.,  53  (5): [PMID:19258262] [10.1128/aac.01065-08]
241. Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S, Hooper DC, Wang M..  (2009)  New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.,  53  (5): [PMID:19258263] [10.1128/aac.01400-08]
242. Ishikawa C, Tsuda T, Konishi H, Nakagawa N, Yamanishi K..  (2009)  Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.,  53  (5): [PMID:19258275] [10.1128/aac.01540-08]
243. Beeton ML, Chalker VJ, Maxwell NC, Kotecha S, Spiller OB..  (2009)  Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.,  53  (5): [PMID:19273669] [10.1128/aac.01349-08]
244. Siira L, Rantala M, Jalava J, Hakanen AJ, Huovinen P, Kaijalainen T, Lyytikäinen O, Virolainen A..  (2009)  Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.,  53  (5): [PMID:19273677] [10.1128/aac.01464-08]
245. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, Wang M..  (2009)  Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.,  53  (5): [PMID:19273684] [10.1128/aac.01684-08]
246. Sader HS, Fritsche TR, Jones RN..  (2009)  Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.,  53  (5): [PMID:19289528] [10.1128/aac.00129-09]
247. Mandomando I, Jaintilal D, Pons MJ, Vallès X, Espasa M, Mensa L, Sigaúque B, Sanz S, Sacarlal J, Macete E, Abacassamo F, Alonso PL, Ruiz J..  (2009)  Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique.,  53  (6): [PMID:19332670] [10.1128/aac.01282-08]
248. Mandsberg LF, Ciofu O, Kirkby N, Christiansen LE, Poulsen HE, Høiby N..  (2009)  Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.,  53  (6): [PMID:19332676] [10.1128/aac.00428-08]
249. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC, Mylonakis E..  (2009)  Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.,  53  (6): [PMID:19332683] [10.1128/aac.01533-08]
250. de Jonge BL, Kutschke A, Uria-Nickelsen M, Kamp HD, Mills SD..  (2009)  Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI).,  53  (8): [PMID:19433553] [10.1128/aac.00226-09]
251. Hu WS, Lin JF, Lin YH, Chang HY..  (2009)  Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium.,  53  (8): [PMID:19470505] [10.1128/aac.00079-09]
252. Kadlec K, Schwarz S..  (2009)  Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain.,  53  (8): [PMID:19470508] [10.1128/aac.00570-09]
253. Zaknoon F, Sarig H, Rotem S, Livne L, Ivankin A, Gidalevitz D, Mor A..  (2009)  Antibacterial properties and mode of action of a short acyl-lysyl oligomer.,  53  (8): [PMID:19487442] [10.1128/aac.00010-09]
254. Sharma M, Joshi P, Kumar N, Joshi S, Rohilla RK, Roy N, Roy N, Rawat DS..  (2011)  Synthesis, antimicrobial activity and structure-activity relationship study of N,N-dibenzyl-cyclohexane-1,2-diamine derivatives.,  46  (2): [PMID:21163555] [10.1016/j.ejmech.2010.11.027]
255. Arumugam N, Periyasami G, Raghunathan R, Kamalraj S, Muthumary J..  (2011)  Synthesis and antimicrobial activity of highly functionalised novel β-lactam grafted spiropyrrolidines and pyrrolizidines.,  46  (2): [PMID:21177001] [10.1016/j.ejmech.2010.11.039]
256. Mansoor UF, Vitharana D, Reddy PA, Daubaras DL, McNicholas P, Orth P, Black T, Siddiqui MA..  (2011)  Design and synthesis of potent Gram-negative specific LpxC inhibitors.,  21  (4): [PMID:21273067] [10.1016/j.bmcl.2010.12.111]
257. Abouzeed YM, Baucheron S, Cloeckaert A..  (2008)  ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.,  52  (7): [PMID:18443112] [10.1128/aac.00084-08]
258. Jeon B, Muraoka W, Sahin O, Zhang Q..  (2008)  Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni.,  52  (8): [PMID:18505858] [10.1128/aac.01607-07]
259. Long F, Rouquette-Loughlin C, Shafer WM, Yu EW..  (2008)  Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.,  52  (9): [PMID:18591276] [10.1128/aac.00475-08]
260. Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, Muto CA, Harrison LH, Doi Y..  (2008)  Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.,  52  (11): [PMID:18725452] [10.1128/aac.00570-08]
261. May T, Ito A, Okabe S..  (2009)  Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes.,  53  (11): [PMID:19721076] [10.1128/aac.00454-09]
262. Srinivasan VB, Rajamohan G, Gebreyes WA..  (2009)  Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.,  53  (12): [PMID:19770280] [10.1128/aac.00748-09]
263. Xu X, Cai L, Xiao M, Kong F, Oftadeh S, Zhou F, Gilbert GL..  (2010)  Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.,  54  (3): [PMID:20065057] [10.1128/aac.01268-09]
264. Morvan A, Moubareck C, Leclercq A, Hervé-Bazin M, Bremont S, Lecuit M, Courvalin P, Le Monnier A..  (2010)  Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.,  54  (6): [PMID:20385859] [10.1128/aac.01557-09]
265. Foss MH, Weibel DB..  (2010)  Oligochlorophens are potent inhibitors of Bacillus anthracis.,  54  (9): [PMID:20566769] [10.1128/aac.00067-10]
266. McDougal LK, Fosheim GE, Nicholson A, Bulens SN, Limbago BM, Shearer JE, Summers AO, Patel JB..  (2010)  Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.,  54  (9): [PMID:20585117] [10.1128/aac.00351-10]
267. Bourne CR, Barrow EW, Bunce RA, Bourne PC, Berlin KD, Barrow WW..  (2010)  Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.,  54  (9): [PMID:20606069] [10.1128/aac.00361-10]
268. Bohnert JA, Karamian B, Nikaido H..  (2010)  Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.,  54  (9): [PMID:20606071] [10.1128/aac.00620-10]
269. Joo HS, Chan JL, Cheung GY, Otto M..  (2010)  Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.,  54  (11): [PMID:20713669] [10.1128/aac.00064-10]
270. Okuda J, Hayashi N, Wakahara Y, Gotoh N..  (2010)  Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.,  54  (11): [PMID:20805389] [10.1128/aac.01652-09]
271. Severin JA, Lestari ES, Kuntaman K, Pastink M, Snijders SV, Lemmens-den Toom N, Horst-Kreft D, Hadi U, Duerink DO, Goessens WH, Fluit AC, van Wamel W, van Belkum A, Verbrugh HA, AMRIN Study Group..  (2010)  Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.,  54  (12): [PMID:20837756] [10.1128/aac.00426-10]
272. Buchholz F, Wolf A, Lerchner J, Mertens F, Harms H, Maskow T..  (2010)  Chip calorimetry for fast and reliable evaluation of bactericidal and bacteriostatic treatments of biofilms.,  54  (1): [PMID:19822705] [10.1128/aac.00583-09]
273. Zhao J, Chen Z, Chen S, Deng Y, Liu Y, Tian W, Huang X, Wu C, Sun Y, Sun Y, Zeng Z, Liu JH..  (2010)  Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.,  54  (10): [PMID:20696876] [10.1128/aac.00139-10]
274. Zhang Y, Bao Q, Gagnon LA, Huletsky A, Oliver A, Jin S, Langaee T..  (2010)  ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.,  54  (11): [PMID:20713660] [10.1128/aac.00009-10]
275. Buvens G, Bogaerts P, Glupczynski Y, Lauwers S, Piérard D..  (2010)  Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.,  54  (11): [PMID:20733038] [10.1128/aac.00551-10]
276. Fessler AT, Kadlec K, Schwarz S..  (2011)  Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates.,  55  (1): [PMID:20876371] [10.1128/aac.01124-10]
277. Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG..  (2011)  Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.,  55  (2): [PMID:21098249] [10.1128/aac.00788-10]
278. Palmieri C, Princivalli MS, Brenciani A, Varaldo PE, Facinelli B..  (2011)  Different genetic elements carrying the tet(W) gene in two human clinical isolates of Streptococcus suis.,  55  (2): [PMID:21115784] [10.1128/aac.00965-10]
279. Awouafack MD, Spiteller P, Lamshöft M, Kusari S, Ivanova B, Tane P, Spiteller M..  (2011)  Antimicrobial isopropenyl-dihydrofuranoisoflavones from Crotalaria lachnophora.,  74  (2): [PMID:21265557] [10.1021/np1005218]
280. Clark RB, He M, Fyfe C, Lofland D, O'Brien WJ, Plamondon L, Sutcliffe JA, Xiao XY..  (2011)  8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.,  54  (5): [PMID:21302930] [10.1021/jm1015389]
281. Lowe R, Glen RC, Mitchell JB..  (2010)  Predicting phospholipidosis using machine learning.,  (5): [PMID:20799726] [10.1021/mp100103e]
282. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ..  (2010)  Developing structure-activity relationships for the prediction of hepatotoxicity.,  23  (7): [PMID:20553011] [10.1021/tx1000865]
283. Ekins S, Williams AJ, Xu JJ..  (2010)  A predictive ligand-based Bayesian model for human drug-induced liver injury.,  38  (12): [PMID:20843939] [10.1124/dmd.110.035113]
284. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A..  (2010)  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.,  23  (1): [PMID:20014752] [10.1021/tx900326k]
285. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF..  (2004)  Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.,  (4): [PMID:16472241] [10.2174/1570163043334794]
286. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF..  (2008)  Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.,  18  (2): [PMID:20020916] [10.1080/15376510701857262]
287. Siddiqui IN, Zahoor A, Hussain H, Ahmed I, Ahmad VU, Padula D, Draeger S, Schulz B, Meier K, Steinert M, Kurtán T, Flörke U, Pescitelli G, Krohn K..  (2011)  Diversonol and blennolide derivatives from the endophytic fungus Microdiplodia sp.: absolute configuration of diversonol.,  74  (3): [PMID:21244021] [10.1021/np100730b]
288. Sirisha K, Bikshapathi D, Achaiah G, Reddy VM..  (2011)  Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.,  46  (5): [PMID:21382653] [10.1016/j.ejmech.2011.02.003]
289. Suresha GP, Suhas R, Kapfo W, Gowda DC..  (2011)  Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials.,  46  (6): [PMID:21481990] [10.1016/j.ejmech.2011.03.041]
290. Sun C, Hunt DK, Clark RB, Lofland D, O'Brien WJ, Plamondon L, Xiao XY..  (2011)  Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs.,  54  (11): [PMID:21500832] [10.1021/jm1015395]
291. Ouyang L, He D, Zhang J, He G, Jiang B, Wang Q, Chen Z, Pan J, Li Y, Guo L..  (2011)  Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.,  19  (12): [PMID:21612935] [10.1016/j.bmc.2011.05.004]
292. Mayer CD, Bracher F..  (2011)  Cytotoxic ring A-modified steroid analogues derived from Grundmann's ketone.,  46  (8): [PMID:21570162] [10.1016/j.ejmech.2011.04.036]
293. Albert S, Horbach R, Deising HB, Siewert B, Csuk R..  (2011)  Synthesis and antimicrobial activity of (E) stilbene derivatives.,  19  (17): [PMID:21803587] [10.1016/j.bmc.2011.07.015]
294. Arshad A, Osman H, Bagley MC, Lam CK, Mohamad S, Zahariluddin AS..  (2011)  Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.,  46  (9): [PMID:21712145] [10.1016/j.ejmech.2011.05.044]
295. Liu J, Li F, Kim EL, Li JL, Hong J, Bae KS, Chung HY, Kim HS, Jung JH..  (2011)  Antibacterial polyketides from the jellyfish-derived fungus Paecilomyces variotii.,  74  (8): [PMID:21744790] [10.1021/np200350b]
296. Shingate BB, Hazra BG, Salunke DB, Pore VS, Shirazi F, Deshpande MV..  (2011)  Stereoselective synthesis and antimicrobial activity of steroidal C-20 tertiary alcohols with thiazole/pyridine side chain.,  46  (9): [PMID:21664730] [10.1016/j.ejmech.2011.05.032]
297. Tukey RH, Strassburg CP..  (2000)  Human UDP-glucuronosyltransferases: metabolism, expression, and disease.,  40  (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581]
298. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, 
299. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W..  (2011)  FDA-approved drug labeling for the study of drug-induced liver injury.,  16  (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007]
300. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W..  (2011)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).,  (12): [PMID:22194678] [10.1371/journal.pcbi.1002310]
301. Zohdi HF, Rateb NM, Elnagdy SM..  (2011)  Green synthesis and antimicrobial evaluation of some new trifluoromethyl-substituted hexahydropyrimidines by grinding.,  46  (11): [PMID:22000920] [10.1016/j.ejmech.2011.09.036]
302. Berest GG, Voskoboynik OY, Kovalenko SI, Antypenko OM, Nosulenko IS, Katsev AM, Shandrovskaya OS..  (2011)  Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.,  46  (12): [PMID:22051065] [10.1016/j.ejmech.2011.10.022]
303. Rejman D, Rabatinová A, Pombinho AR, Kovačková S, Pohl R, Zborníková E, Kolář M, Bogdanová K, Nyč O, Sanderová H, Látal T, Bartůněk P, Krásný L..  (2011)  Lipophosphonoxins: new modular molecular structures with significant antibacterial properties.,  54  (22): [PMID:22007704] [10.1021/jm2009343]
304. Aly HM, Kamal MM..  (2012)  Efficient one-pot preparation of novel fused chromeno[2,3-d]pyrimidine and pyrano[2,3-d]pyrimidine derivatives.,  47  [PMID:22000923] [10.1016/j.ejmech.2011.09.040]
305. Arumugam N, Raghunathan R, Almansour AI, Karama U..  (2012)  An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.,  22  (3): [PMID:22230048] [10.1016/j.bmcl.2011.12.061]
306. Xiao XY, Hunt DK, Zhou J, Clark RB, Dunwoody N, Fyfe C, Grossman TH, O'Brien WJ, Plamondon L, Rönn M, Sun C, Zhang WY, Sutcliffe JA..  (2012)  Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.,  55  (2): [PMID:22148514] [10.1021/jm201465w]
307. Brucoli F, Natoli A, Marimuthu P, Borrello MT, Stapleton P, Gibbons S, Schätzlein A..  (2012)  Efficient synthesis and biological evaluation of proximicins A, B and C.,  20  (6): [PMID:22364744] [10.1016/j.bmc.2012.01.043]
308. Shiu WK, Rahman MM, Curry J, Stapleton P, Zloh M, Malkinson JP, Gibbons S..  (2012)  Antibacterial acylphloroglucinols from Hypericum olympicum.,  75  (3): [PMID:21899267] [10.1021/np2003319]
309. Sarkar A, Anderson KC, Kellogg GE..  (2012)  Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.,  52  [PMID:22483632] [10.1016/j.ejmech.2012.03.008]
310. Jubie S, Ramesh PN, Dhanabal P, Kalirajan R, Muruganantham N, Antony AS..  (2012)  Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.,  54  [PMID:22770606] [10.1016/j.ejmech.2012.06.025]
311. Clark RB, Hunt DK, He M, Achorn C, Chen CL, Deng Y, Fyfe C, Grossman TH, Hogan PC, O'Brien WJ, Plamondon L, Rönn M, Sutcliffe JA, Zhu Z, Xiao XY..  (2012)  Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.,  55  (2): [PMID:22148555] [10.1021/jm201467r]
312. Hossein nia R, Mamaghani M, Tabatabaeian K, Shirini F, Rassa M..  (2012)  An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction.,  22  (18): [PMID:22892120] [10.1016/j.bmcl.2012.07.059]
313. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE..  (2012)  Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.,  25  (10): [PMID:22931300] [10.1021/tx300075j]
314. Babu E, Takeda M, Narikawa S, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Sakthisekaran D, Endou H..  (2002)  Human organic anion transporters mediate the transport of tetracycline.,  88  (1): [PMID:11855680] [10.1254/jjp.88.69]
315. Rodrigues T, Prudêncio M, Moreira R, Mota MM, Lopes F..  (2012)  Targeting the liver stage of malaria parasites: a yet unmet goal.,  55  (3): [PMID:22122518] [10.1021/jm201095h]
316. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
317. Liu XT, Schwan WR, Volk TJ, Rott M, Liu M, Huang P, Liu Z, Wang Y, Zitomer NC, Sleger C, Hartsel S, Monte A, Zhang L..  (2012)  Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.,  75  (9): [PMID:22934636] [10.1021/np300221a]
318. Sangaraiah N, Murugan S, Poovan S, Raja R, Alagusundaram P, Ramakrishnan V, Vellasamy S..  (2012)  Facile water promoted synthesis of 1,2,3-triazolyl dihydropyrimidine-2-thione hybrids - highly potent antibacterial agents.,  58  [PMID:23151322] [10.1016/j.ejmech.2012.10.029]
319. Parhi A, Lu S, Kelley C, Kaul M, Pilch DS, LaVoie EJ..  (2012)  Antibacterial activity of substituted dibenzo[a,g]quinolizin-7-ium derivatives.,  22  (22): [PMID:23058886] [10.1016/j.bmcl.2012.08.123]
320. Moreno L, Párraga J, Galán A, Cabedo N, Primo J, Cortes D..  (2012)  Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.,  20  (22): [PMID:23062823] [10.1016/j.bmc.2012.09.033]
321. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P..  (2012)  Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.,  55  (10): [PMID:22541068] [10.1021/jm300212s]
322. Parhi A, Kelley C, Kaul M, Pilch DS, LaVoie EJ..  (2012)  Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives.,  22  (23): [PMID:23084900] [10.1016/j.bmcl.2012.09.097]
323. Kelley C, Zhang Y, Parhi A, Kaul M, Pilch DS, LaVoie EJ..  (2012)  3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.,  20  (24): [PMID:23127490] [10.1016/j.bmc.2012.10.009]
324. Altundas A, Ayvaz S, Logoglu E.  (2011)  Synthesis and evaluation of a series of aminocyanopyridines as antimicrobial agents,  20  (1): [10.1007/s00044-009-9273-x]
325. Ceylan M, Gurdere MB, Karaman I, Gezegen H.  (2011)  The synthesis and screening of the antimicrobial activity of some novel 3-(furan-2-yl)-1-(aryl)-3-(phenylthio) propan-1-one derivatives,  20  (1): [10.1007/s00044-009-9279-4]
326. Kaya M, Basar E, Colak F.  (2011)  Synthesis and antimicrobial activity of some bisoctahydroxanthene-1,8-dione derivatives,  20  (8): [10.1007/s00044-010-9459-2]
327. Sadeghian A, Pordel M, Safdari H, Fahmidekar MA, Sadeghian H.  (2012)  11-Chloro-3-methyl-3H-imidazo[4,5-a]acridine (CMIA) as a potent and selective antimicrobial agent against clinical isolates of highly antibiotic-resistant Acinetobacter baumannii,  21  (11): [10.1007/s00044-011-9933-5]
328. Logoglu E, Yilmaz M, Katircioglu H, Yakut M, Mercan S.  (2010)  Synthesis and biological activity studies of furan derivatives,  19  (5): [10.1007/s00044-009-9206-8]
329. Sagir T, Gencer S, Kemikli N, Abasiyanik MF, Isik S, Ozturk R.  (2012)  Photodynamic activities of protoporphyrin IX and its dopamine conjugate against cancer and bacterial cell viability,  21  (12): [10.1007/s00044-011-9951-3]
330. Gaonkar S, Rai KL, Prabhuswamy B.  (2006)  Synthesis of novel 3-[5-ethyl-2-(2-phenoxy-ethyl)-pyridin]-5-substituted isoxazoline libraries via 1,3-dipolar cycloaddition and evaluation of antimicrobial activities,  15  (7): [10.1007/s00044-006-0015-z]
331. Yavuz S, Aydn O, Cete S, Disli A, Yldrr Y.  (2010)  Synthesis and antimicrobial activity studies of some novel substituted phenylhydrazono-1H-tetrazol-5-yl-acetonitriles,  19  (2): [10.1007/s00044-009-9177-9]
332. Wei W, Wang H, Jiang C.  (2008)  Study of the inactivation of copper, zinc superoxide dismutase by tetracycline analogues,  17  (8): [10.1007/s00044-007-9020-0]
333. Katrcoglu H, Logoglu E, Tilki T, Oktemer A.  (2007)  Synthesis of 2,4-dihalogenofluorobenzenes and their antimicrobial and antifungal activity studies,  16  (5): [10.1007/s00044-007-9024-9]
334. Aslan HG, Karacan N.  (2013)  Aromatic sulfonyl hydrazides and sulfonyl hydrazones: antimicrobial activity and physical properties,  22  (3): [10.1007/s00044-012-0104-0]
335. Hussain H, Ahmed I, Schulz B, Draeger S, Krohn K..  (2012)  Pyrenocines J-M: four new pyrenocines from the endophytic fungus, Phomopsis sp.,  83  (3): [PMID:22233864] [10.1016/j.fitote.2011.12.017]
336. Kovalenko SI, Nosulenko IS, Voskoboynik AY, Berest GG, Antipenko LN, Antipenko AN, Katsev AM.  (2013)  Novel N-aryl(alkaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides: synthesis, cytotoxicity, anticancer activity, COMPARE analysis and docking,  22  (6): [10.1007/s00044-012-0257-x]
337. Kelley C, Lu S, Parhi A, Kaul M, Pilch DS, Lavoie EJ..  (2013)  Antimicrobial activity of various 4- and 5-substituted 1-phenylnaphthalenes.,  60  [PMID:23314053] [10.1016/j.ejmech.2012.12.027]
338. Koyama N, Tokura Y, Takahashi Y, Tomoda H..  (2013)  Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.,  23  (3): [PMID:23265883] [10.1016/j.bmcl.2012.11.044]
339. Zhang Y, Giurleo D, Parhi A, Kaul M, Pilch DS, LaVoie EJ..  (2013)  Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.,  23  (7): [PMID:23481648] [10.1016/j.bmcl.2013.02.016]
340. Barker CA, Allison SE, Zlitni S, Nguyen ND, Das R, Melacini G, Capretta AA, Brown ED..  (2013)  Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.,  23  (8): [PMID:23473681] [10.1016/j.bmcl.2013.02.005]
341. Galán A, Moreno L, Párraga J, Serrano Á, Sanz MJ, Cortes D, Cabedo N..  (2013)  Novel isoquinoline derivatives as antimicrobial agents.,  21  (11): [PMID:23601815] [10.1016/j.bmc.2013.03.042]
342. Parhi AK, Zhang Y, Saionz KW, Pradhan P, Kaul M, Trivedi K, Pilch DS, LaVoie EJ..  (2013)  Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.,  23  (17): [PMID:23891185] [10.1016/j.bmcl.2013.06.048]
343. Settimo L, Bellman K, Knegtel RM..  (2013)  Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.,  [PMID:24249037] [10.1007/s11095-013-1232-z]
344. Ola AR, Thomy D, Lai D, Brötz-Oesterhelt H, Proksch P..  (2013)  Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.,  76  (11): [PMID:24175613] [10.1021/np400589h]
345. Tiruveedhula VV, Witzigmann CM, Verma R, Kabir MS, Rott M, Schwan WR, Medina-Bielski S, Lane M, Close W, Polanowski RL, Sherman D, Monte A, Deschamps JR, Cook JM..  (2013)  Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.,  21  (24): [PMID:24200931] [10.1016/j.bmc.2013.10.011]
346. Odžak R, Skočibušić M, Maravić A..  (2013)  Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.,  21  (23): [PMID:24126094] [10.1016/j.bmc.2013.09.041]
347. Ningaiah S, Bhadraiah UK, Doddaramappa SD, Keshavamurthy S, Javarasetty C..  (2014)  Novel pyrazole integrated 1,3,4-oxadiazoles: synthesis, characterization and antimicrobial evaluation.,  24  (1): [PMID:24316123] [10.1016/j.bmcl.2013.11.029]
348. Stoilova T, Colombo L, Forloni G, Tagliavini F, Salmona M..  (2013)  A new face for old antibiotics: tetracyclines in treatment of amyloidoses.,  56  (15): [PMID:23611039] [10.1021/jm400161p]
349. Villinski JR, Bergeron C, Cannistra JC, Gloer JB, Coleman CM, Ferreira D, Azelmat J, Grenier D, Gafner S..  (2014)  Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis.,  77  (3): [PMID:24479468] [10.1021/np400788r]
350. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R..  (2004)  [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs].,  28  (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2]
351. PubChem BioAssay data set, 
352. Yadav S, Joshi S, Qadar Pasha MA, Pasha S.  (2013)  Antimicrobial activity and mode of action of novel, N-terminal tagged tetra-peptidomimetics,  (5): [10.1039/C3MD20311E]
353. Basarab GS, Manchester JI, Bist S, Boriack-Sjodin PA, Dangel B, Illingworth R, Sherer BA, Sriram S, Uria-Nickelsen M, Eakin AE..  (2013)  Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.,  56  (21): [PMID:24098982] [10.1021/jm401208b]
354. Temburnikar KW, Zimmermann SC, Kim NT, Ross CR, Gelbmann C, Salomon CE, Wilson GM, Balzarini J, Seley-Radtke KL..  (2014)  Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.,  22  (7): [PMID:24631358] [10.1016/j.bmc.2014.02.033]
355. Grier N, Dybas RA, Strelitz RA, Witzel BE, Dulaney EL..  (1979)  Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts.,  22  (11): [PMID:533889] [10.1021/jm00197a024]
356. Tseng YY, Liou JM, Hsu TL, Cheng WC, Wu MS, Wong CH..  (2014)  Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.,  24  (11): [PMID:24775303] [10.1016/j.bmcl.2014.04.041]
357. Singh H, Singh AK, Sharma S, Iyer RN, Srivastava OP..  (1977)  Synthesis of 5-chloro-3'-nitro-4'-substituted salicylanilides, a new series of anthelmintic and antimicrobial agents.,  20  (6): [PMID:874957] [10.1021/jm00216a017]
358. Dasyam N, Munkacsi AB, Fadzilah NH, Senanayake DS, O'Toole RF, Keyzers RA..  (2014)  Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.,  77  (6): [PMID:24856903] [10.1021/np500171z]
359. Emirdağ-Öztürk S, Karayıldırım T, Çapcı-Karagöz A, Alankuş-Çalışkan Ö, Özmen A, Poyrazoğlu-Çoban E..  (2014)  Synthesis, antimicrobial and cytotoxic activities, and structure-activity relationships of gypsogenin derivatives against human cancer cells.,  82  [PMID:24941130] [10.1016/j.ejmech.2014.05.084]
360. Liu Y, Wray V, Abdel-Aziz MS, Wang CY, Lai D, Proksch P..  (2014)  Trimeric anthracenes from the endophytic fungus Stemphylium globuliferum.,  77  (7): [PMID:25010124] [10.1021/np500113r]
361. Kukowska M, Kukowska-Kaszuba M, Dzierzbicka K..  (2015)  In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections.,  25  (3): [PMID:25556094] [10.1016/j.bmcl.2014.12.029]
362. Lele DS, Talat S, Kumari S, Srivastava N, Kaur KJ..  (2015)  Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide.,  92  [PMID:25617693] [10.1016/j.ejmech.2015.01.032]
363. Sun X, Sun S, Ference C, Zhu W, Zhou N, Zhang Y, Zhou K..  (2015)  A potent antimicrobial compound isolated from Clathria cervicornis.,  25  (1): [PMID:25435146] [10.1016/j.bmcl.2014.11.012]
364. Whalen KE, Poulson-Ellestad KL, Deering RW, Rowley DC, Mincer TJ..  (2015)  Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp.,  78  (3): [PMID:25646964] [10.1021/np500775e]
365. Sun C, Hunt DK, Chen CL, Deng Y, He M, Clark RB, Fyfe C, Grossman TH, Sutcliffe JA, Xiao XY..  (2015)  Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.,  58  (11): [PMID:25927406] [10.1021/acs.jmedchem.5b00262]
366. Boulangé A, Parraga J, Galán A, Cabedo N, Leleu S, Sanz MJ, Cortes D, Franck X..  (2015)  Synthesis and antibacterial activities of cadiolides A, B and C and analogues.,  23  (13): [PMID:25913865] [10.1016/j.bmc.2015.04.010]
367. Magoulas GE, Kostopoulou ON, Garnelis T, Athanassopoulos CM, Kournoutou GG, Leotsinidis M, Dinos GP, Papaioannou D, Kalpaxis DL..  (2015)  Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.,  23  (13): [PMID:26001343] [10.1016/j.bmc.2015.04.069]
368. Sola I, Castellà S, Viayna E, Galdeano C, Taylor MC, Gbedema SY, Pérez B, Clos MV, Jones DC, Fairlamb AH, Wright CW, Kelly JM, Muñoz-Torrero D..  (2015)  Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity.,  23  (16): [PMID:25678015] [10.1016/j.bmc.2015.01.031]
369. El-Gendy Bel-D, Rateb ME..  (2015)  Antibacterial activity of diketopiperazines isolated from a marine fungus using t-butoxycarbonyl group as a simple tool for purification.,  25  (16): [PMID:26099531] [10.1016/j.bmcl.2015.06.010]
370. Doddaramappa SD, Lokanatha Rai KM, Srikantamurthy N, Chandra, Chethan J..  (2015)  Novel 5-functionalized-pyrazoles: Synthesis, characterization and pharmacological screening.,  25  (17): [PMID:26152425] [10.1016/j.bmcl.2015.06.050]
371. Viveka S, Dinesha, Shama P, Nagaraja GK, Ballav S, Kerkar S..  (2015)  Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.,  101  [PMID:26186150] [10.1016/j.ejmech.2015.07.002]
372. McKinney DC, Basarab GS, Cocozaki AI, Foulk MA, Miller MD, Ruvinsky AM, Scott CW, Thakur K, Zhao L, Buurman ET, Narayan S..  (2015)  Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens.,  (8): [PMID:26288696] [10.1021/acsmedchemlett.5b00205]
373. Shymanska NV, An IH, Guevara-Zuluaga S, Pierce JG..  (2015)  Rapid synthesis and antimicrobial activity of novel 4-oxazolidinone heterocycles.,  25  (21): [PMID:26099542] [10.1016/j.bmcl.2015.06.003]
374. Ma M, Rateb ME, Teng Q, Yang D, Rudolf JD, Zhu X, Huang Y, Zhao LX, Jiang Y, Li X, Rader C, Duan Y, Shen B..  (2015)  Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion.,  78  (10): [PMID:26335269] [10.1021/acs.jnatprod.5b00601]
375. Jin J, Cui J, Chaudhary AS, Hsieh YH, Damera K, Zhang H, Yang H, Wang B, Tai PC..  (2015)  Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus.,  23  (21): [PMID:26432604] [10.1016/j.bmc.2015.09.027]
376. Wang H, Hong J, Yin J, Moon HR, Liu Y, Wei X, Oh DC, Jung JH..  (2015)  Dimeric Octaketide Spiroketals from the Jellyfish-Derived Fungus Paecilomyces variotii J08NF-1.,  78  (11): [PMID:26562481] [10.1021/acs.jnatprod.5b00594]
377. Assimon VA, Shao H, Garneau-Tsodikova S, Gestwicki JE..  (2015)  Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity.,  (5): [PMID:27087913] [10.1039/c4md00572d]
378. Fu HG, Hu XX, Li CR, Li YH, Wang YX, Jiang JD, Bi CW, Tang S, You XF, Song DQ..  (2016)  Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.,  110  [PMID:26827160] [10.1016/j.ejmech.2016.01.024]
379. Havrylyuk D, Roman O, Lesyk R..  (2016)  Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.,  113  [PMID:26922234] [10.1016/j.ejmech.2016.02.030]
380. Wang B, Pachaiyappan B, Gruber JD, Schmidt MG, Zhang YM, Woster PM..  (2016)  Antibacterial Diamines Targeting Bacterial Membranes.,  59  (7): [PMID:26964758] [10.1021/acs.jmedchem.5b01912]
381. Garrison AT, Abouelhassan Y, Norwood VM, Kallifidas D, Bai F, Nguyen MT, Rolfe M, Burch GM, Jin S, Luesch H, Huigens RW..  (2016)  Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.,  59  (8): [PMID:27018907] [10.1021/acs.jmedchem.5b02004]
382. Hicks RP..  (2016)  Antibacterial and anticancer activity of a series of novel peptides incorporating cyclic tetra-substituted C(α) amino acids.,  24  (18): [PMID:27387357] [10.1016/j.bmc.2016.06.048]
383. WHO Anatomical Therapeutic Chemical Classification, 
384. British National Formulary (72nd edition), 
385. Liu ML, Pan XY, Yang T, Zhang WM, Wang TQ, Wang HY, Lin HX, Yang CG, Cui YM..  (2016)  The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.,  26  (22): [PMID:27777007] [10.1016/j.bmcl.2016.10.018]
386. Helfenstein A, Vahermo M, Nawrot DA, Demirci F, İşcan G, Krogerus S, Yli-Kauhaluoma J, Moreira VM, Tammela P..  (2017)  Antibacterial profiling of abietane-type diterpenoids.,  25  (1): [PMID:27793449] [10.1016/j.bmc.2016.10.019]
387. Perković I, Antunović M, Marijanović I, Pavić K, Ester K, Kralj M, Vlainić J, Kosalec I, Schols D, Hadjipavlou-Litina D, Pontiki E, Zorc B..  (2016)  Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.,  124  [PMID:27614409] [10.1016/j.ejmech.2016.08.021]
388. Janeczko M, Demchuk OM, Strzelecka D, Kubiński K, Masłyk M..  (2016)  New family of antimicrobial agents derived from 1,4-naphthoquinone.,  124  [PMID:27783973] [10.1016/j.ejmech.2016.10.034]
389. Naik NS, Shastri LA, Joshi SD, Dixit SR, Chougala BM, Samundeeswari S, Holiyachi M, Shaikh F, Madar J, Kulkarni R, Sunagar V..  (2017)  3,4-Dihydropyrimidinone-coumarin analogues as a new class of selective agent against S. aureus: Synthesis, biological evaluation and molecular modelling study.,  25  (4): [PMID:28094219] [10.1016/j.bmc.2017.01.001]
390. Open TG-GATES,  [10.6019/CHEMBL3885861]
391. DrugMatrix,  [10.6019/CHEMBL3885881]
392. Zang Y, Genta-Jouve G, Escargueil AE, Larsen AK, Guedon L, Nay B, Prado S..  (2016)  Antimicrobial Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus.,  79  (12): [PMID:27966935] [10.1021/acs.jnatprod.6b00458]
393. Vajs J, Proud C, Brozovic A, Gazvoda M, Lloyd A, Roper DI, Osmak M, Košmrlj J, Dowson CG..  (2017)  Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.,  127  [PMID:28063354] [10.1016/j.ejmech.2016.12.060]
394. Zhang WM, Yang T, Pan XY, Liu XL, Lin HX, Gao ZB, Yang CG, Cui YM..  (2017)  The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7.,  127  [PMID:27837995] [10.1016/j.ejmech.2016.11.002]
395. Deng Y, Sun C, Hunt DK, Fyfe C, Chen CL, Grossman TH, Sutcliffe JA, Xiao XY..  (2017)  Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosa.,  60  (6): [PMID:28248499] [10.1021/acs.jmedchem.6b01903]
396. Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK..  (2010)  Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.,  118  (2): [PMID:20829430] [10.1093/toxsci/kfq269]
397. Wijesekera K, Mahidol C, Ruchirawat S, Kittakoop P..  (2017)  Metabolite diversification by cultivation of the endophytic fungus Dothideomycete sp. in halogen containing media: Cultivation of terrestrial fungus in seawater.,  25  (11): [PMID:28366267] [10.1016/j.bmc.2017.03.040]
398. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK..  (2013)  A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.,  136  (1): [PMID:23956101] [10.1093/toxsci/kft176]
399. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W..  (2016)  DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.,  21  (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015]
400. Mason DJ, Stott I, Ashenden S, Weinstein ZB, Karakoc I, Meral S, Kuru N, Bender A, Cokol M..  (2017)  Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.,  60  (9): [PMID:28383902] [10.1021/acs.jmedchem.7b00204]
401. Pospisilova S, Michnova H, Kauerova T, Pauk K, Kollar P, Vinsova J, Imramovsky A, Cizek A, Jampilek J..  (2018)  In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.,  28  (12): [PMID:29773506] [10.1016/j.bmcl.2018.05.011]
402. Sirajuddin M, McKee V, Tariq M, Ali S..  (2018)  Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.,  143  [PMID:29133050] [10.1016/j.ejmech.2017.11.001]
403. Mohsin NU, Seebacher W, Faist J, Hochegger P, Kaiser M, Mäser P, Belaj F, Saf R, Kretschmer N, Alajlani M, Turek I, Brantner A, Bauer R, Bucar F, Weis R..  (2018)  Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.,  143  [PMID:29172086] [10.1016/j.ejmech.2017.11.025]
404. Xu K, He S, Chen S, Qiu G, Shi J, Liu X, Wu X, Zhang J, Tang W..  (2018)  Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.,  154  [PMID:29787914] [10.1016/j.ejmech.2018.05.021]
405. Nair JJ, Wilhelm A, Bonnet SL, van Staden J..  (2017)  Antibacterial constituents of the plant family Amaryllidaceae.,  27  (22): [PMID:29033234] [10.1016/j.bmcl.2017.09.052]
406. Kwon J, Mistry T, Ren J, Johnson ME, Mehboob S..  (2018)  A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.,  26  (1): [PMID:29162308] [10.1016/j.bmc.2017.11.018]
407. Cerulli A, Lauro G, Masullo M, Cantone V, Olas B, Kontek B, Nazzaro F, Bifulco G, Piacente S..  (2017)  Cyclic Diarylheptanoids from Corylus avellana Green Leafy Covers: Determination of Their Absolute Configurations and Evaluation of Their Antioxidant and Antimicrobial Activities.,  80  (6): [PMID:28520428] [10.1021/acs.jnatprod.6b00703]
408. Mangasuli SN, Hosamani KM, Devarajegowda HC, Kurjogi MM, Joshi SD..  (2018)  Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents.,  146  [PMID:29407993] [10.1016/j.ejmech.2018.01.025]
409. Zhang WM, Yao Y, Yang T, Wang XY, Zhu ZY, Xu WT, Lin HX, Gao ZB, Zhou H, Yang CG, Cui YM..  (2018)  The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.,  28  (10): [PMID:29650291] [10.1016/j.bmcl.2018.03.062]
410. Edwards L, Turner D, Champion C, Khandelwal M, Zingler K, Stone C, Rajapaksha RD, Yang J, Ranasinghe MI, Kornienko A, Frolova LV, Rogelj S..  (2018)  Photoactivated 2,3-distyrylindoles kill multi-drug resistant bacteria.,  28  (10): [PMID:29673980] [10.1016/j.bmcl.2018.04.001]
411. Consoli GML, Granata G, Picciotto R, Blanco AR, Geraci C, Marino A, Nostro A..  (2018)  Design, synthesis and antibacterial evaluation of a polycationic calix[4]arene derivative alone and in combination with antibiotics.,  (1): [PMID:30108909] [10.1039/C7MD00527J]
412. Schinke C, Martins T, Queiroz SCN, Melo IS, Reyes FGR..  (2017)  Antibacterial Compounds from Marine Bacteria, 2010-2015.,  80  (4): [PMID:28362500] [10.1021/acs.jnatprod.6b00235]
413. Unpublished dataset, 
414. Kaweewan I, Hemmi H, Komaki H, Harada S, Kodani S..  (2018)  Isolation and structure determination of a new lasso peptide specialicin based on genome mining.,  26  (23-24): [PMID:30448257] [10.1016/j.bmc.2018.11.007]
415. Thamban Chandrika N, Fosso MY, Alimova Y, May A, Gonzalez OA, Garneau-Tsodikova S..  (2019)  Novel zafirlukast derivatives exhibit selective antibacterial activity against Porphyromonas gingivalis.,  10  (6): [PMID:31303990] [10.1039/C9MD00074G]
416. Abouelhassan Y, Garrison AT, Yang H, Chávez-Riveros A, Burch GM, Huigens RW..  (2019)  Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.,  62  (17): [PMID:30951303] [10.1021/acs.jmedchem.9b00370]
417. Gao F, Wang T, Xiao J, Huang G..  (2019)  Antibacterial activity study of 1,2,4-triazole derivatives.,  173  [PMID:31009913] [10.1016/j.ejmech.2019.04.043]
418. Antoszczak M, Huczyński A..  (2019)  Salinomycin and its derivatives - A new class of multiple-targeted "magic bullets".,  176  [PMID:31103901] [10.1016/j.ejmech.2019.05.031]
419. Garner AL, Lorenz DA, Sandoval J, Gallagher EE, Kerk SA, Kaur T, Menon A..  (2019)  Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.,  10  (5): [PMID:31098005] [10.1021/acsmedchemlett.9b00091]
420. Patil PC, Tan J, Demuth DR, Luzzio FA..  (2019)  'Second-generation' 1,2,3-triazole-based inhibitors of Porphyromonas gingivalis adherence to oral streptococci and biofilm formation.,  10  (2): [PMID:30881614] [10.1039/C8MD00405F]
421. Long Y, Tang T, Wang LY, He B, Gao K..  (2019)  Absolute Configuration and Biological Activities of Meroterpenoids from an Endophytic Fungus of Lycium barbarum.,  82  (8): [PMID:31397570] [10.1021/acs.jnatprod.9b00288]
422. Su L, Li J, Zhou Z, Huang D, Zhang Y, Pei H, Guo W, Wu H, Wang X, Liu M, Yang CG, Chen Y..  (2019)  Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents.,  162  [PMID:30447433] [10.1016/j.ejmech.2018.11.016]
423. Gatadi S, Lakshmi TV, Nanduri S..  (2019)  4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads.,  170  [PMID:30884322] [10.1016/j.ejmech.2019.03.018]
424. Hansen AM, Bonke G, Hogendorf WFJ, Björkling F, Nielsen J, Kongstad KT, Zabicka D, Tomczak M, Urbas M, Nielsen PE, Franzyk H..  (2019)  Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.,  168  [PMID:30807888] [10.1016/j.ejmech.2019.02.024]
425. Zhang W, Lun S, Liu LL, Xiao S, Duan G, Gunosewoyo H, Yang F, Tang J, Bishai WR, Yu LF..  (2019)  Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.,  62  (7): [PMID:30875203] [10.1021/acs.jmedchem.9b00010]
426. Castro I, Fabre N, Bourgeade-Delmas S, Saffon N, Gandini C, Sauvain M, Castillo D, Bourdy G, Jullian V..  (2019)  Structural Characterization and Anti-infective Activity of 9,10-Seco-29-norcycloartane Glycosides Isolated from the Flowers of the Peruvian Medicinal Plant Cordia lutea.,  82  (12): [PMID:31800248] [10.1021/acs.jnatprod.9b00149]
427. Sala S, Fromont J, Gomez O, Vuong D, Lacey E, Flematti GR..  (2019)  Albanitriles A-G: Antiprotozoal Polyacetylene Nitriles from a Mycale Marine Sponge.,  82  (12): [PMID:31833368] [10.1021/acs.jnatprod.9b00840]
428. Kim A, Kim MJ, Noh TH, Hong J, Liu Y, Wei X, Jung JH..  (2016)  Synthesis and antibacterial evaluation of hamacanthin B analogues.,  26  (20): [PMID:27614413] [10.1016/j.bmcl.2016.08.095]
429.  (2018)  Substituted urea depsipeptide analogs as activators of the clpp endopeptidase, 
430. Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V..  (2016)  Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,  79  (4): [PMID:26998557] [10.1021/acs.jnatprod.5b01129]
431. Rana P, Will Y, Nadanaciva S, Jones LH..  (2016)  Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.,  26  (16): [PMID:27397500] [10.1016/j.bmcl.2016.06.088]
432. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection,  [10.6019/CHEMBL4513141]
433. Bae J, Cho E, Park JS, Won TH, Seo SY, Oh DC, Oh KB, Shin J..  (2020)  Isocadiolides A-H: Polybrominated Aromatics from a Synoicum sp. Ascidian.,  83  (2): [PMID:31967465] [10.1021/acs.jnatprod.9b00968]
434. Shin YH, Kang S, Byun WS, Jeon CW, Chung B, Beom JY, Hong S, Lee J, Shin J, Kwak YS, Lee SK, Oh KB, Yoon YJ, Oh DC..  (2020)  Absolute Configuration and Antibiotic Activity of Piceamycin.,  83  (2): [PMID:32073848] [10.1021/acs.jnatprod.9b00678]
435. Menegatti C, Lourenzon VB, Rodríguez-Hernández D, da Paixão Melo WG, Ferreira LLG, Andricopulo AD, do Nascimento FS, Pupo MT..  (2020)  Meliponamycins: Antimicrobials from Stingless Bee-Associated Streptomyces sp.,  83  (3): [PMID:32073851] [10.1021/acs.jnatprod.9b01011]
436. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]
437. Zhang J,Huang H,Zhou X,Xu Y,Chen B,Tang W,Xu K.  (2019)  N-Benzylanilines as Fatty Acid Synthesis Inhibitors against Biofilm-related Methicillin-resistant Staphylococcus aureus.,  10  (3.0): [PMID:30891135] [10.1021/acsmedchemlett.8b00612]
438. Camp, Jason E., Nyamini, Simbarashe B., Scott, Fraser J..  (2020)  Cyrene(TM) is a green alternative to DMSO as a solvent for antibacterial drug discovery against ESKAPE pathogens,  11  (1): [PMID:33479610] [10.1039/c9md00341j]
439. Patil PS,Kasare SL,Haval NB,Khedkar VM,Dixit PP,Rekha EM,Sriram D,Haval KP.  (2020)  Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.,  30  (19): [PMID:32717369] [10.1016/j.bmcl.2020.127434]
440. Patel MB,Garrad EC,Stavri A,Gokel MR,Negin S,Meisel JW,Cusumano Z,Gokel GW.  (2016)  Hydraphiles enhance antimicrobial potency against Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis.,  24  (12): [PMID:27166575] [10.1016/j.bmc.2016.04.058]
441. Salem MA,Ragab A,Askar AA,El-Khalafawy A,Makhlouf AH.  (2020)  One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.,  188  [PMID:31927313] [10.1016/j.ejmech.2019.111977]
442. Amabili P,Biavasco F,Brenciani A,Citterio B,Corbisiero D,Ferrazzano L,Fioriti S,Guerra G,Orena M,Rinaldi S.  (2020)  Simple amphiphilic α-hydrazido acids: Rational design, synthesis, and in vitro bioactivity profile of a novel class of potential antimicrobial compounds.,  189  [PMID:31991335] [10.1016/j.ejmech.2020.112072]
443. Oliveri V.  (2019)  Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.,  167  [PMID:30743095] [10.1016/j.ejmech.2019.01.045]
444. Phatak PS,Bakale RD,Kulkarni RS,Dhumal ST,Dixit PP,Krishna VS,Sriram D,Khedkar VM,Haval KP.  (2020)  Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.,  30  (22): [PMID:32987135] [10.1016/j.bmcl.2020.127579]
445. Howard KC,Gonzalez OA,Garneau-Tsodikova S.  (2020)  Second Generation of Zafirlukast Derivatives with Improved Activity against the Oral Pathogen Porphyromonas gingivalis.,  11  (10): [PMID:33062172] [10.1021/acsmedchemlett.9b00614]
446. Patel, Anjali, Dey, Subhasis, Shokeen, Kamal, Karpinski, Tomasz M., Sivaprakasam, Senthilkumar, Kumar, Sachin, Manna, Debasis.  (2021)  Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity,  12  (6.0): [PMID:34223166] [10.1039/d1md00091h]
447. Zhang W,Liu LL,Lun S,Wang SS,Xiao S,Gunosewoyo H,Yang F,Tang J,Bishai WR,Yu LF.  (2021)  Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.,  213  [PMID:33516983] [10.1016/j.ejmech.2021.113202]
448. Unpublished dataset, 
449. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius.  (2021)  HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators,  [10.6019/CHEMBL4808148]
450. Bracegirdle J, Stevenson LJ, Sharrock AV, Page MJ, Vorster JA, Owen JG, Ackerley DF, Keyzers RA..  (2021)  Hydrated Rubrolides from the New Zealand Tunicate Synoicum kuranui.,  84  (2.0): [PMID:33496582] [10.1021/acs.jnatprod.0c01248]
451. Jin E, Li H, Liu Z, Xiao F, Li W..  (2021)  Antibiotic Dixiamycins from a Cold-Seep-Derived Streptomyces olivaceus.,  84  (9.0): [PMID:34410142] [10.1021/acs.jnatprod.1c00411]
452. Zhang PL, Gopala L, Zhang SL, Cai GX, Zhou CH..  (2022)  An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.,  229  [PMID:34922190] [10.1016/j.ejmech.2021.114050]
453. Huynh TH, Lee J, Moon DH, Nguyen TQ, Son S, Hwang S, Du YE, Cui J, Jang JH, Nam SJ, Shin J, Jang J, Lee SK, Oh KB, Oh DC..  (2022)  Gwanakosides A and B, 6-Deoxy-α-l-talopyranose-Bearing Aromatic Metabolites from a Streptomyces sp. and Coculture with Pandoraea sp.,  85  (1.0): [PMID:34931849] [10.1021/acs.jnatprod.1c00703]
454. Howard KC, Garneau-Tsodikova S..  (2022)  Selective Inhibition of the Periodontal Pathogen Porphyromonas gingivalis by Third-Generation Zafirlukast Derivatives.,  65  (21.0): [PMID:36273428] [10.1021/acs.jmedchem.2c01471]
455. Guo Y, Yang Y, Xu X, Li L, Zhou Y, Jia G, Wei L, Yu Q, Wang J..  (2022)  Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.,  231  [PMID:35101651] [10.1016/j.ejmech.2022.114108]
456. Deka B, Suri M, Sarma S, Devi MV, Bora A, Sen T, Dihingia A, Pahari P, Singh AK..  (2022)  Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.,  54  [PMID:34953341] [10.1016/j.bmc.2021.116580]
457. Dewangan RP, Verma DP, Verma NK, Gupta A, Pant G, Mitra K, Habib S, Ghosh JK..  (2022)  Spermine-Conjugated Short Proline-Rich Lipopeptides as Broad-Spectrum Intracellular Targeting Antibacterial Agents.,  65  (7.0): [PMID:35297625] [10.1021/acs.jmedchem.1c01809]
458. Mohammed EHM, Lohan S, Tiwari RK, Parang K..  (2022)  Amphiphilic cyclic peptide [W4KR5]-Antibiotics combinations as broad-spectrum antimicrobial agents.,  235  [PMID:35339840] [10.1016/j.ejmech.2022.114278]
459. Brandão P, Marques C, Burke AJ, Pineiro M..  (2021)  The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules.,  211  [PMID:33421712] [10.1016/j.ejmech.2020.113102]
460. Mohammed EHM, Lohan S, Ghaffari T, Gupta S, Tiwari RK, Parang K..  (2022)  Membrane-Active Cyclic Amphiphilic Peptides: Broad-Spectrum Antibacterial Activity Alone and in Combination with Antibiotics.,  65  (23.0): [PMID:36442155] [10.1021/acs.jmedchem.2c01469]
461. Hammouda MM, Gaffer HE, Elattar KM..  (2022)  Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-a]pyrimidine scaffold.,  13  (10.0): [PMID:36325400] [10.1039/d2md00192f]
462. Ahmad S, Alam O, Naim MJ, Shaquiquzzaman M, Alam MM, Iqbal M..  (2018)  Pyrrole: An insight into recent pharmacological advances with structure activity relationship.,  157  [PMID:30119011] [10.1016/j.ejmech.2018.08.002]
463. James PJC, Vuong D, Moggach SA, Lacey E, Piggott MJ..  (2023)  Synthesis, Characterization, and Bioactivity of the Lichen Pigments Pulvinamide, Rhizocarpic Acid, and Epanorin and Congeners.,  86  (3): [PMID:36897305] [10.1021/acs.jnatprod.2c01013]
464. Sala S, James PJC, Nealon GL, Fromont J, Gomez O, Vuong D, Lacey E, Flematti GR..  (2023)  Dendrillic Acids A and B: Nitrogenous, Rearranged Spongian Nor-Diterpenes from a Dendrilla sp. Marine Sponge.,  86  (3): [PMID:36926864] [10.1021/acs.jnatprod.2c01087]
465. Sutherland JJ, Yonchev D, Fekete A, Urban L..  (2023)  A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.,  14  (1): [PMID:37468498] [10.1038/s41467-023-40064-9]